Soft tissue disorders related to use, overuse and pressure

M13_SOFTOVERUSE

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — M70 Cause of death: ICD-10 — M70 2 out of 7 registries used, show all original rules.	12016
4. Check minimum number of events None	12016
5. Include endpoints M13_CHRONSYNOVITISHANDWRIST M13_OLECRANONBURSITIS M13_BURSELBOWOTH M13_PREPATELLARBURSITIS M13_BURSITISKNEEOTH M13_TROCHANTERICBURSITIS M13_BURSITISHIPOTH M13_OVERUSENAS	12651
6. Filter based on genotype QC (FinnGen only)	12651

Control definitions (FinnGen only)

Control exclude: M13_SOFTTISSUE

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: M70-M79
Name in latin: Morbositates textus mollis ad usum, abusum et/sive pressionem pertinentes

NAME	M13_SOFTOVERUSE
CONTROL_EXCLUDE	M13_SOFTTISSUE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	M13_CHRONSYNOVITISHANDWRIST\|M13_OLECRANONBURSITIS\|M13_BURSELBOWOTH\|M13_PREPATELLARBURSITIS\|M13_BURSITISKNEEOTH\|M13_TROCHANTERICBURSITIS\|M13_BURSITISHIPOTH\|M13_OVERUSENAS
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	M70
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	M70
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Soft tissue disorders related to use, overuse and pressure based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	81252	41020	39896
Only index persons	76692	39389	37303
Unadjusted period prevalence (%)
Whole population	1.14	1.17	1.11
Only index persons	1.44	1.45	1.42
Median age at first event (years)
Whole population	54.57	58.16	50.87
Only index persons	54.11	57.76	50.25

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	12651	7409	5242
Unadjusted period prevalence (%)	2.44	2.53	2.31
Median age at first event (years)	56.48	56.99	55.76

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
11105: Matched controls
111050

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

M19.0

ICD-10 Finland

Primary arthrosis of other joints

4.3

323.3

1309

3316

M70.8

ICD-10 Finland

Other soft tissue disorders related to use, overuse and pressure

68.5

323.0

695

108

M70.2

ICD-10 Finland

Olecranon bursitis

32.8

323.0

2134

801

N03AX12

ATC

gabapentin; oral

4.4

323.0

2442

6702

M03BX02

ATC

tizanidine; oral

2.3

323.0

7201

49310

M48.0

ICD-10 Finland

Spinal stenosis

3.8

323.0

1746

5165

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

2.8

323.0

5822

31368

M70.7

ICD-10 Finland

Other bursitis of hip

15.3

323.0

960

683

N03AX16

ATC

pregabalin; oral

3.8

323.0

3571

12179

M70.6

ICD-10 Finland

Trochanteric bursitis

21.6

323.0

5468

4764

N02AJ06

ATC

codeine and paracetamol; systemic

2.6

323.0

4650

23770

N02BE01

ATC

paracetamol; systemic, rectal

3.1

323.0

9809

78518

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

3.9

323.0

2182

6610

M01AH05

ATC

etoricoxib; oral

2.9

323.0

7368

44973

H02AB06

ATC

prednisolone; systemic

2.2

323.0

5417

33398

NBG15

NOMESCO Finland

Acromioplastia, arthroscopic

19.9

323.0

857

465

M79.6

ICD-10 Finland

Pain in limb

4.7

323.0

4961

16349

L13

ICPC

Hip symptom/complaint

3.7

323.0

2509

8179

M70.4

ICD-10 Finland

Prepatellar bursitis

52.7

323.0

1472

321

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

4.5

323.0

1862

4793

M75.1

ICD-10 Finland

Rotator cuff syndrome

5.0

323.0

3119

8082

J01DB01

ATC

cefalexin; oral

2.9

323.0

9399

72907

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

5.0

323.0

1310

2909

M25.5

ICD-10 Finland

Pain in joint

3.5

323.0

4091

15800

N02AX02

ATC

tramadol; systemic, rectal

3.2

323.0

5649

27371

M54.4

ICD-10 Finland

Lumbago with sciatica

4.1

323.0

2605

7770

M01AB05

ATC

diclofenac; systemic, rectal

2.4

323.0

7735

54627

M54.5

ICD-10 Finland

Low back pain

3.2

323.0

4499

19693

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

5.2

323.0

1697

3698

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

13.0

323.0

888

736

A02BC02

ATC

pantoprazole; systemic

2.3

323.0

7490

52172

M79.0

ICD-10 Finland

Rheumatism, unspecified

41.3

323.0

599

153

N06AX21

ATC

duloxetine; oral

3.8

314.9

1517

4491

M70.5

ICD-10 Finland

Other bursitis of knee

23.0

311.7

459

208

L03

ICPC

Low back symptom/complaint

2.6

311.3

2912

13541

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.3

310.5

4027

22143

M01AC06

ATC

meloxicam; systemic, rectal

2.2

309.5

4382

25099

M79.1

ICD-10 Finland

Myalgia

3.7

305.1

1507

4547

M03BC01

ATC

orphenadrine (citrate); systemic

2.5

298.0

2851

13370

M70.0

ICD-10 Finland

Chronic crepitant synovitis of hand and wrist

79.5

285.5

324

M01AH01

ATC

celecoxib; oral (coxibs)

2.7

284.0

2304

9797

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

9.4

283.8

613

685

M01AE02

ATC

naproxen; oral, rectal

2.1

282.5

6269

42958

NCM20

NOMESCO Finland

Excision of synovial ganglion of elbow or forearm

134.9

282.0

302

M70.9

ICD-10 Finland

Unspecified soft tissue disorder related to use, overuse and pressure

33.0

276.5

368

115

A02BC05

ATC

esomeprazole; systemic

2.1

275.8

4687

28665

L08

ICPC

Shoulder symptom/complaint

2.7

274.6

2211

9336

M02AA07

ATC

piroxicam; topical

2.1

273.6

4224

24768

M79.7

ICD-10 Finland

Fibromyalgia

13.3

271.8

491

384

M17.1

ICD-10 Finland

Other primary gonarthrosis

2.5

266.6

2523

11654

J01FF01

ATC

clindamycin; systemic

2.3

266.4

3290

17388

R03AC02

ATC

salbutamol; inhalant

2.0

263.9

5787

39005

NFM20

NOMESCO Finland

Excision of bursa of hip or thigh

875.3

262.4

257

G56.0

ICD-10 Finland

Carpal tunnel syndrome

3.1

261.9

1630

5812

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

3.6

258.3

1321

4066

N06AA09

ATC

amitriptyline; systemic

3.5

252.9

1341

4244

S18

ICPC

Laceration/cut

2.0

249.5

4674

29366

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

4.2

249.1

1024

2604

NDM40

NOMESCO Finland

Discission of sheath of tendon of wrist or hand

54.4

247.3

297

M01AE03

ATC

ketoprofen; systemic, rectal

2.0

241.5

4279

26188

R07.4

ICD-10 Finland

Chest pain, unspecified

2.2

241.3

3068

16287

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

4.5

241.3

919

2167

M54.9

ICD-10 Finland

Dorsalgia, unspecified

3.2

238.8

1406

4799

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.2

235.0

3268

18019

L17

ICPC

Foot/toe symptom/complaint

2.2

231.9

2820

14617

ZXA00

NOMESCO Finland

Right side

2.2

231.2

3104

16828

R51.80

ICD-10 Finland

Headache

2.8

228.9

1658

6490

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

2.1

227.1

3215

17815

A02BC03

ATC

lansoprazole; oral

2.1

226.1

3363

19022

J01DA01

ATC

[U] cefalexin; systemic

1.9

219.2

6882

51364

7266E

ICD-9 Finland

Peripheral enthesopathies and allied syndromes, Enthesopathy of knee[BURSITIS PRAEPATELLARIS]

+∞

215.3

206

J01AA02

ATC

doxycycline; systemic

2.0

215.0

8590

69797

M01AX17

ATC

nimesulide; oral

2.2

214.9

2828

15107

M70.3

ICD-10 Finland

Other bursitis of elbow

22.0

212.9

317

148

NF1AA

NOMESCO Finland

Hip X-ray examination

3.3

208.0

1171

3846

M76.0

ICD-10 Finland

Gluteal tendinitis

13.3

206.2

372

289

NE1CG

NOMESCO Finland

Pelvic, hip and femur extensive MRI examination with high intensity magnet

8.4

206.0

475

589

M01AH02

ATC

rofecoxib; oral

2.7

205.0

1620

6651

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

2.3

204.3

2268

11157

M75.0

ICD-10 Finland

Adhesive capsulitis of shoulder

6.4

204.3

570

935

X59

ICD-10 Finland

Exposure to unspecified factor

2.4

204.2

2091

9885

L15

ICPC

Knee symptom/complaint

2.3

202.3

2351

11812

M16.1

ICD-10 Finland

Other primary coxarthrosis

2.8

201.0

1452

5641

A02BC01

ATC

omeprazole; systemic

2.1

200.5

3081

17487

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

2.0

199.7

3204

18501

G44.2

ICD-10 Finland

Tension-type headache

2.7

199.7

1525

6126

ZXA05

NOMESCO Finland

Left side

2.1

198.1

2831

15580

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.5

197.4

1850

8340

M54.3

ICD-10 Finland

Sciatica

4.0

195.4

841

2214

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

2.8

195.1

1432

5610

S46.0

ICD-10 Finland

Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder

3.6

194.3

964

2865

M77.1

ICD-10 Finland

Lateral epicondylitis

4.0

191.4

826

2179

R06.0

ICD-10 Finland

Dyspnoea

2.1

190.8

2686

14644

M01AE01

ATC

ibuprofen; systemic, rectal

2.2

189.6

9754

84725

J01.0

ICD-10 Finland

Acute maxillary sinusitis

2.2

189.1

2338

12039

NGM20

NOMESCO Finland

Excision of synovial ganglion of knee or lower leg

55.4

186.4

223

J45.9

ICD-10 Finland

Asthma, unspecified

2.3

183.7

1978

9531

M67.4

ICD-10 Finland

Ganglion

5.3

182.8

592

1165

UJF32

NOMESCO Finland

Coloscopy

2.0

182.6

2856

16214

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.8

181.0

4637

31443

Z01.8

ICD-10 Finland

Other specified special examinations

2.1

180.9

2377

12540

A46

ICD-10 Finland

Erysipelas

2.4

178.9

1687

7590

9473

FHL

Local soft tissue removal or exploration (eg Bursa)

34.2

175.3

231

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.8

175.0

4239

28116

M03BC51

ATC

orphenadrine, combinations; systemic

1.9

173.4

3069

18208

7263C

ICD-9 Finland

Peripheral enthesopathies and allied syndromes, Enthesopathy of elbow region[BURSITIS OLECRANI]

+∞

173.3

166

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.9

172.0

1186

4447

J01MA02

ATC

ciprofloxacin; systemic

1.8

171.0

4137

27367

X58

ICD-10 Finland

Exposure to other specified factors

2.5

170.2

1538

6752

NE1AA

NOMESCO Finland

Pelvis X-ray examination

3.4

165.8

879

2740

NBL00

NOMESCO Finland

Suture or reinsertation of rotator cuff of shoulder

5.1

165.8

554

1128

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

3.1

164.7

988

3371

NBG10

NOMESCO Finland

Acromioplastia

18.3

164.4

260

145

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

4.8

163.9

587

1288

WX110

NOMESCO Finland

Local anesthesy

1.7

163.6

7190

56925

R52.9

ICD-10 Finland

Pain, unspecified

3.1

163.4

994

3425

A06AC01

ATC

ispaghula (psylla seeds); oral

2.0

162.2

2646

15152

A02BA02

ATC

ranitidine; systemic

2.1

161.6

2174

11510

L28

ICPC

Limited function/disability (L)

2.3

161.6

1685

7944

M65.3

ICD-10 Finland

Trigger finger

7.4

157.6

393

549

N06AX11

ATC

mirtazapine; oral

1.8

157.5

3370

21246

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

3.7

155.8

746

2142

A01

ICPC

Pain general/multiple sites

3.1

153.9

910

3067

M01AX05

ATC

glucosamine; oral

2.1

153.8

2178

11751

M71.0

ICD-10 Finland

Abscess of bursa

41.2

153.5

194

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.2

153.3

1905

9721

R42

ICD-10 Finland

Dizziness and giddiness

2.0

152.7

2297

12695

NBA30

NOMESCO Finland

Exploration of joint of shoulder or upper arm, arthroscopic

11.4

151.7

293

263

SPAT1153

SPAT

Removal of sutures

1.8

151.6

3332

21132

M53.1

ICD-10 Finland

Cervicobrachial syndrome

2.7

150.3

1177

4746

WX320

NOMESCO Finland

Spinalanesthesy

2.0

149.6

2427

13799

J01FA06

ATC

roxithromycin; oral

1.7

149.4

4269

29396

M13.9

ICD-10 Finland

Arthritis, unspecified

3.1

148.4

874

2936

R4110

NOMESCO Finland

Physiotherapy

1.9

148.3

2883

17506

M02AA10

ATC

ketoprofen; topical

2.2

147.8

1770

8867

M77.4

ICD-10 Finland

Metatarsalgia

4.2

147.2

595

1470

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

5.1

145.7

487

990

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

4.1

145.3

614

1580

R01AD09

ATC

mometasone; nasal

1.7

144.8

4584

32450

M72.2

ICD-10 Finland

Plantar fascial fibromatosis

3.3

144.5

800

2569

J01CA04

ATC

amoxicillin; systemic

1.8

144.5

8447

71310

M47.82

ICD-10 Finland

Other spondylosis, cervical region

4.5

144.4

540

1236

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

3.8

143.4

649

1774

NDM20

NOMESCO Finland

Excision of synovial ganglion of wrist or hand

32.9

141.6

188

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

2.8

141.4

983

3682

L12

ICPC

Hand/finger symptom/complaint

2.3

141.4

1466

6853

P01AB01

ATC

metronidazole; oral, rectal

1.7

141.1

4136

28555

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

2.4

140.3

1281

5614

M54.2

ICD-10 Finland

Cervicalgia

3.2

139.5

804

2655

J01FA10

ATC

azithromycin; systemic

1.6

137.7

5883

45062

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.1

136.6

1780

9224

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.2

136.1

1666

8401

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

2.3

135.4

1447

6853

M76.8

ICD-10 Finland

Other enthesopathies of lower limb, excluding foot

11.1

134.7

264

244

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.6

133.8

5175

38452

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.7

132.7

4103

28624

B01AB05

ATC

enoxaparin; parenteral

1.8

132.5

3167

20448

N02AA05

ATC

oxycodone; systemic

2.2

131.9

1526

7491

J02AC01

ATC

fluconazole; systemic

1.7

130.8

4060

28322

SAA01

NOMESCO Finland

Simple examination of mouth

1.6

130.1

7174

58422

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

2.0

129.9

1820

9699

R03DC03

ATC

montelukast; oral

2.1

127.9

1664

8594

R06AE07

ATC

cetirizine; oral

1.7

127.4

4394

31492

M54.1

ICD-10 Finland

Radiculopathy

4.3

127.3

499

1195

N05CF01

ATC

zopiclone; oral

1.7

126.9

3334

22099

M16.9

ICD-10 Finland

Coxarthrosis, unspecified

3.3

126.6

676

2108

M01AB55

ATC

diclofenac, combinations; oral

2.9

126.0

814

2902

M54.6

ICD-10 Finland

Pain in thoracic spine

3.1

125.2

756

2574

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.6

125.0

5631

43255

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.4

124.8

1162

5124

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

3.0

124.4

763

2626

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

2.0

124.0

1829

9927

L86

ICPC

Back syndrome with radiating pain

3.3

123.7

679

2160

N06CA01

ATC

amitriptyline and psycholeptics; systemic

2.4

123.6

1144

5029

M47.9

ICD-10 Finland

Spondylosis, unspecified

4.7

123.5

444

975

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.6

123.4

4851

35913

M72.0

ICD-10 Finland

Palmar fascial fibromatosis [Dupuytren]

12.7

123.0

225

180

L10

ICPC

Elbow symptom/complaint

3.6

122.5

592

1706

L01

ICPC

Neck symptom/complaint

2.2

121.6

1373

6647

SPAT1263

SPAT

Sampling

1.6

121.6

4247

30429

R05

ICD-10 Finland

Cough

1.9

120.7

1992

11278

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

4.5

119.9

453

1046

R52.2

ICD-10 Finland

Other chronic pain

5.0

118.7

405

841

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

3.8

118.6

540

1480

R60.0

ICD-10 Finland

Localized oedema

2.4

118.4

1155

5208

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

9.4

118.4

253

275

H02AB04

ATC

methylprednisolone; systemic

2.1

116.8

1554

8072

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

2.2

116.8

1270

6036

ACC51

NOMESCO Finland

Release of median nerve

2.9

115.6

773

2814

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

2.3

115.5

1162

5319

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.4

115.1

1097

4887

NB1CG

NOMESCO Finland

Shoulder and humerus extensive MRI examination with high intensity magnet

9.5

114.7

243

260

R05

ICPC

Cough

1.8

114.6

2199

13107

P01BA02

ATC

hydroxychloroquine; oral

2.6

113.9

926

3789

R53

ICD-10 Finland

Malaise and fatigue

1.9

113.6

1991

11489

WX408

NOMESCO Finland

General anesthesy, balanced

1.7

113.5

2750

17663

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.7

113.0

2770

17851

J01FA09

ATC

clarithromycin; systemic

1.7

112.8

3215

21657

C03CA01

ATC

furosemide; systemic

1.7

111.6

2685

17191

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

3.2

110.8

639

2103

L16

ICPC

Ankle symptom/complaint

2.4

110.7

1023

4480

AA1AD

NOMESCO Finland

CT of head and brain

1.8

110.3

2372

14654

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.7

109.3

2772

18013

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

2.4

109.2

1027

4539

C07AB07

ATC

bisoprolol; oral

1.6

109.0

4693

35165

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.9

108.7

1934

11202

WX002

NOMESCO Finland

Sedation and analgesia

1.8

108.3

2060

12206

Z71.8

ICD-10 Finland

Other specified counselling

1.8

107.3

2318

14319

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.7

107.1

2550

16238

NBG00

NOMESCO Finland

Plastic operation on acromioclavicular joint

15.6

106.3

178

116

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

2.2

106.2

1184

5677

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

2.5

105.8

903

3787

H02BX01

ATC

methylprednisolone, combinations; systemic

3.2

105.6

608

1998

ACC59

NOMESCO Finland

Decompression and freeing of adhesions of peripheral nerve: other or unspecified

3.5

105.2

528

1565

M76.6

ICD-10 Finland

Achilles tendinitis

4.1

105.2

431

1074

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

7.5

105.2

257

348

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.6

104.9

3317

22888

NBT60

NOMESCO Finland

Forcible manipulation of humeroscapular joint

20.4

104.8

159

N06AX16

ATC

venlafaxine; oral

2.1

104.7

1379

7109

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.6

104.4

4108

29996

NDM10

NOMESCO Finland

Palmar fasciotomy of hand

32.0

104.2

139

M43.1

ICD-10 Finland

Spondylolisthesis

3.6

103.1

502

1453

M01AC01

ATC

piroxicam; systemic, rectal

2.0

103.0

1434

7559

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.3

102.3

998

4485

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.5

102.0

5218

40509

M53.0

ICD-10 Finland

Cervicocranial syndrome

2.5

101.0

847

3517

M54

ICD-10 Finland

Dorsalgia

2.2

100.8

1153

5587

M71.1

ICD-10 Finland

Other infective bursitis

40.2

100.3

127

M16.0

ICD-10 Finland

Primary coxarthrosis, bilateral

2.7

100.2

759

2973

R01BA52

ATC

pseudoephedrine, combinations; oral

1.6

99.7

3160

21755

L02

ICPC

Back symptom/complaint

2.4

99.6

899

3881

NGA30

NOMESCO Finland

Exploration of knee joint, arthroscopic

3.1

99.3

574

1890

SPAT1203

SPAT

Injection therapy, other than intramuscular or subcutaneous

3.4

98.6

503

1510

NBF25

NOMESCO Finland

Operation for humeroscapular osteochondritis, arthroscopic

8.7

98.1

219

257

S80.0

ICD-10 Finland

Contusion of knee

2.8

98.0

691

2592

R02

ICPC

Shortness of breath/dyspnoea

2.1

97.4

1189

5921

NBL22

NOMESCO Finland

Myotomy, tenotomy or excision of tendon of upper arm

13.0

95.8

173

135

R03AK07

ATC

formoterol and budesonide; inhalant

1.8

95.7

1909

11439

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.0

95.7

1367

7261

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

2.7

95.5

707

2732

SPAT1212

SPAT

Extensive examination of musculoskeletal system

2.5

95.3

844

3604

R01AD08

ATC

fluticasone; nasal

1.6

95.2

2795

18800

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

4.8

94.7

335

722

Z50.1

ICD-10 Finland

Other physical therapy

2.9

94.5

611

2170

J01MA12

ATC

levofloxacin; systemic

1.8

94.3

1856

11063

M71.9

ICD-10 Finland

Bursopathy, unspecified

11.1

94.1

183

167

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.1

93.9

1227

6285

K02.1

ICD-10 Finland

Caries of dentine

1.5

93.9

5541

44104

M77.9

ICD-10 Finland

Enthesopathy, unspecified

4.8

93.6

327

696

SAA02

NOMESCO Finland

Basic examination of mouth

1.5

93.4

6264

51257

G47.3

ICD-10 Finland

Sleep apnoea

1.7

92.6

2108

13155

M70.1

ICD-10 Finland

Bursitis of hand

75.8

92.3

105

7261X

ICD-9 Finland

Peripheral enthesopathies and allied syndromes, Rotator cuff syndrome of shoulder and allied disorders[MUU TAI TARKEMMIN MÄÄRITTELEM KIERTÄJÄKALVOSINSDR]

+∞

90.7

L87

ICPC

Bursitis/tendinitis/synovitis NOS

6.0

90.2

258

435

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

6.9

90.1

233

343

E0000UV

ATC

1.5

89.7

3803

27979

SPAT1149

SPAT

Suture or treatment of traumatic wound

2.0

89.5

1289

6856

TPH04

NOMESCO Finland

Cathetrisation of vein

1.7

89.4

2050

12805

R03BA02

ATC

budesonide; inhalant

1.8

88.5

1713

10135

R5599

NOMESCO Finland

Other rehabilitation service

4.5

88.1

329

750

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.6

88.0

2910

20121

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.6

87.6

674

2660

R05FB02

ATC

cough suppressants and expectorants

1.5

87.6

3758

27680

R03BA05

ATC

fluticasone; inhalant

1.8

87.5

1750

10459

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

5.8

86.9

257

452

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.5

86.6

4363

33310

NB1BG

NOMESCO Finland

Shoulder and humerus MRI examination with high intensity magnet

7.7

86.3

208

276

R07.3

ICD-10 Finland

Other chest pain

2.2

86.3

926

4341

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

2.1

86.1

1016

4971

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.8

85.8

1584

9216

A07EC01

ATC

sulfasalazine; oral, rectal

2.3

85.7

840

3771

H04.10

ICD-10 Finland

Dry eye syndrome

2.2

85.4

995

4840

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.8

85.2

1704

10177

M01AB08

ATC

etodolac; oral

2.4

84.9

796

3493

J01EA01

ATC

trimethoprim; systemic

1.6

84.6

2416

16037

N01

ICPC

Headache

2.3

84.6

870

3996

R74

ICPC

Upper respiratory infection acute

1.6

84.2

2490

16686

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

1.7

84.1

1943

12134

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.5

83.8

5598

45280

R06AX27

ATC

desloratadine; oral

1.6

83.6

2513

16905

K30

ICD-10 Finland

Functional dyspepsia

2.1

83.5

1026

5106

H02AB07

ATC

prednisone; oral

1.9

83.5

1421

8030

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.3

83.4

842

3831

TNX00

SPAT

12.4

83.0

153

125

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.3

83.0

827

3742

M65.4

ICD-10 Finland

Radial styloid tenosynovitis [de Quervain]

6.1

82.8

234

389

WZA90

NOMESCO Finland

Other doctors statement

1.7

82.6

2181

14156

G54.0

ICD-10 Finland

Brachial plexus disorders

5.2

82.5

268

527

M77.0

ICD-10 Finland

Medial epicondylitis

5.4

81.7

258

491

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

4.2

81.7

324

783

L29

ICPC

Musculoskeletal sympt/complt other

2.4

81.7

748

3243

NG1BG

NOMESCO Finland

Knee and lower leg MRI examination with high intensity magnet

3.5

81.2

410

1219

SPAT1249

SPAT

Treatment-related counselling outside office

1.5

81.0

3772

28171

S93.4

ICD-10 Finland

Sprain and strain of ankle

2.2

80.8

908

4345

G56.2

ICD-10 Finland

Lesion of ulnar nerve

4.0

80.7

345

893

NH1BG

NOMESCO Finland

Ankle and foot MRI examination with high intensity magnet

6.7

80.1

212

323

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

4.2

79.1

319

783

R4120

NOMESCO Finland

Occupational therapy

2.6

79.0

637

2578

D07AC01

ATC

betamethasone; topical

1.5

78.6

3310

24125

M75.2

ICD-10 Finland

Bicipital tendinitis

5.7

78.5

234

416

N05BA04

ATC

oxazepam; oral

1.6

78.4

2380

16008

R01AD12

ATC

fluticasone furoate; nasal

1.6

78.3

2733

19048

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.3

78.0

752

3345

Z01.2

ICD-10 Finland

Dental examination

1.5

78.0

3876

29298

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.3

77.9

792

3612

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.9

77.7

1332

7534

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

3.6

77.6

376

1082

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.7

77.6

2020

13026

UKC02

NOMESCO Finland

Cystoscopy

1.8

77.6

1464

8552

S06.0

ICD-10 Finland

Concussion

2.1

76.8

964

4835

M75.3

ICD-10 Finland

Calcific tendinitis of shoulder

7.5

76.4

186

251

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

2.0

76.0

1040

5402

M01AX01

ATC

nabumetone; oral

2.9

75.6

480

1678

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.3

75.5

786

3623

R03BA01

ATC

beclometasone; inhalant

1.8

75.4

1361

7826

WX290

NOMESCO Finland

Other blockade of nerve

1.5

75.4

4058

31134

M35.7

ICD-10 Finland

Hypermobility syndrome

8.8

75.1

165

189

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.0

74.8

1088

5786

R96

ICPC

Asthma

2.2

74.8

856

4122

D11

ICPC

Diarrhoea

2.0

74.4

987

5060

D01

ICPC

Abdominal pain/cramps general

2.1

74.3

965

4904

N04BC05

ATC

pramipexole; oral

2.3

74.2

719

3204

R05FA02

ATC

opium derivatives and expectorants; systemic

1.5

74.0

3929

30022

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.6

73.9

2468

16972

N03AE01

ATC

clonazepam; systemic

2.5

73.8

597

2420

NC1AA

NOMESCO Finland

Elbow X-ray examination without contrast

3.5

73.7

362

1053

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.4

73.6

692

3034

NHL16

NOMESCO Finland

Tenolysis or tenosynovectomy of achilles tendon

42.1

73.6

7265A

ICD-9 Finland

Peripheral enthesopathies and allied syndromes, Enthesopathy of hip region[BURSITIS TROCHANTERICA]

+∞

73.0

I10

ICD-10 Finland

Essential (primary) hypertension

1.4

72.7

5697

46983

N05BA01

ATC

diazepam; systemic, rectal

1.8

72.5

1305

7490

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.9

72.5

1145

6276

T84.0

ICD-10 Finland

Mechanical complication of internal joint prosthesis

3.4

72.4

368

1100

M19.1

ICD-10 Finland

Post-traumatic arthrosis of other joints

4.1

72.4

294

727

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

2.4

72.1

680

2986

G04BD12

ATC

mirabegron; oral

2.0

71.4

975

5056

R03AC03

ATC

terbutaline; inhalant

1.8

71.1

1347

7863

E66.01

ICD-10 Finland

Obesity due to excess calories

2.3

70.6

730

3351

L14

ICPC

Leg/thigh symptom/complaint

2.3

70.4

685

3055

SPAT1229

SPAT

Assessment of need for aid

2.2

70.2

782

3717

SPAT1301

SPAT

No procedures

1.5

70.1

2940

21290

J45.1

ICD-10 Finland

Nonallergic asthma

2.3

69.9

680

3033

M01AB01

ATC

indometacin; systemic, rectal

2.2

69.9

758

3559

M54.8

ICD-10 Finland

Other dorsalgia

3.1

69.9

415

1389

M75.8

ICD-10 Finland

Other shoulder lesions

3.8

69.8

315

855

M65.8

ICD-10 Finland

Other synovitis and tenosynovitis

5.7

69.8

207

366

N02AC04

ATC

dextropropoxyphene; oral

3.2

69.7

382

1209

ZXA10

NOMESCO Finland

Bilateral

1.7

69.6

1781

11389

S29

ICPC

Skin symptom/complaint other

1.7

69.5

1551

9530

M10.9

ICD-10 Finland

Gout, unspecified

2.4

69.2

621

2659

D07AB02

ATC

hydrocortisone butyrate; topical

1.5

68.7

2641

18727

ABC56

NOMESCO Finland

Decompression of lumbar spinal canal and nerve roots

3.9

68.7

300

792

M65.9

ICD-10 Finland

Synovitis and tenosynovitis, unspecified

5.0

68.5

230

470

A03FA02

ATC

cisapride; oral, rectal

2.2

68.2

758

3600

R21

ICPC

Throat symptom/complaint

1.7

68.1

1618

10122

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.2

68.1

731

3416

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.8

67.8

1270

7379

A06AD11

ATC

lactulose; oral

1.8

67.8

1278

7440

M71.2

ICD-10 Finland

Synovial cyst of popliteal space [Baker]

4.0

67.8

283

718

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.6

67.3

542

2189

M75.9

ICD-10 Finland

Shoulder lesion, unspecified

3.0

67.2

414

1421

XA402

NOMESCO Finland

ENMG

4.0

67.1

284

729

NBL05

NOMESCO Finland

Arthroscopic suture or reinsertation of rotator cuff of shoulder

9.5

67.1

141

150

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

2.2

66.9

720

3369

N30.0

ICD-10 Finland

Acute cystitis

1.8

66.8

1268

7394

M19.9

ICD-10 Finland

Arthrosis, unspecified

3.1

66.7

392

1303

J01CE02

ATC

phenoxymethylpenicillin; oral

1.4

66.6

6821

58686

NB2AT

NOMESCO Finland

Intra artrial injection of shoulder with ultrasound guidance

9.3

66.6

142

155

SPAT1216

SPAT

Assessment of functional ability

1.8

66.5

1391

8369

NAG62

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, 2-3 vertebraea

4.3

66.5

255

597

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.4

66.5

3933

30525

M76.9

ICD-10 Finland

Enthesopathy of lower limb, unspecified

8.1

66.5

154

193

K59.09

ICD-10 Finland

Constipation, unspecified

2.4

66.1

585

2487

A04

ICPC

Weakness/tiredness general

1.9

66.0

1141

6449

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

3.5

66.0

323

938

J45

ICD-10 Finland

Asthma

2.0

65.8

922

4821

M67.8

ICD-10 Finland

Other specified disorders of synovium and tendon

16.4

65.6

107

SAA03

NOMESCO Finland

Extended examination of mouth

1.5

65.4

3529

26867

WX200

NOMESCO Finland

Interscalenous plexus blockade

5.5

65.0

200

370

M16

ICD-10 Finland

Coxarthrosis [arthrosis of hip]

2.6

65.0

493

1925

M01AH03

ATC

valdecoxib; oral

2.3

64.9

651

2946

73109

ICD-8 Finland

Synovitis, bursitis and tenosynovitis, Unspecified

+∞

64.6

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.1

64.3

754

3664

TQW40

NOMESCO Finland

Remowal of suture of skin

2.2

64.1

710

3363

M02AA15

ATC

diclofenac; topical (antiinflammatory prep., non-steroids for topical use)

2.1

64.1

764

3739

L11

ICPC

Wrist symptom/complaint

2.2

64.1

705

3329

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.6

63.9

1961

13127

SPAT1312

SPAT

General health counselling

1.5

63.6

2923

21498

R52.0

ICD-10 Finland

Acute pain

3.5

63.5

317

935

M20.4

ICD-10 Finland

Other hammer toe(s) (acquired)

2.8

63.5

434

1593

H01

ICPC

Ear pain/earache

2.0

63.3

910

4804

W19

ICD-10 Finland

Unspecified fall

2.0

63.2

861

4450

M15

ICD-10 Finland

Polyarthrosis

2.6

63.0

485

1909

M50.3

ICD-10 Finland

Other cervical disc degeneration

4.1

63.0

258

643

XF400

NOMESCO Finland

ECG with 12 standard connections

1.7

62.8

1511

9466

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.5

62.8

3105

23178

L03.0

ICD-10 Finland

Cellulitis of finger and toe

2.2

62.5

675

3162

M20.1

ICD-10 Finland

Hallux valgus (acquired)

2.1

62.3

797

4016

N05CF02

ATC

zolpidem; oral

1.6

62.2

1651

10627

J20

ICD-10 Finland

Acute bronchitis

2.0

62.2

896

4732

SHB00

NOMESCO Finland

Prepation and fitting of bite rail to mouth

2.0

62.0

806

4087

N06AB04

ATC

citalopram; systemic

1.6

61.6

2001

13577

M15.0

ICD-10 Finland

Primary generalized (osteo)arthrosis

3.5

61.4

303

885

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.1

61.4

708

3412

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.9

61.2

1050

5908

S43.4

ICD-10 Finland

Sprain and strain of shoulder joint

3.3

61.0

324

1002

1220

FHL

Arthroscopy

2.8

60.7

403

1451

U02

ICPC

Urinary frequency/urgency

1.8

60.5

1194

7035

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.9

60.5

1022

5721

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.6

60.3

481

1931

D07AC13

ATC

mometasone; topical

1.5

60.0

2729

19978

R03BB04

ATC

tiotropium bromide; inhalant

1.9

59.4

884

4722

SPAT1255

SPAT

Intravenous administration of medicine

2.2

59.4

643

3012

A02BA04

ATC

nizatidine; systemic

2.1

59.1

743

3713

W22

ICD-10 Finland

Striking against or struck by other object(s)

2.3

59.1

564

2488

NCL22

NOMESCO Finland

Myotomy or tenotomy of elbow or forearm

155.8

58.9

A02BC04

ATC

rabeprazole; oral

2.0

58.8

792

4073

NAG40

NOMESCO Finland

Anterior fusion of cervical spine without fixation

3.9

58.8

254

665

A28

ICPC

Limited function/disability NOS

1.7

58.4

1295

7905

NA6BG

NOMESCO Finland

Sacro-iliac joint MRI examination with high intensity magnet

5.6

58.4

177

322

73398

ICD-8 Finland

Other diseases of muscle, tendon and fascia, Alii definiti

+∞

58.4

M04AA01

ATC

allopurinol; systemic

1.8

58.3

1126

6589

9242

FHL

Other reconstruction or plastic surgery of shoulder joint (including ac joint)

8.4

58.2

131

157

M22.4

ICD-10 Finland

Chondromalacia patellae

3.3

58.2

305

934

R09

ICPC

Sinus symptom/complaint

2.2

57.9

662

3177

D06

ICPC

Abdominal pain localized other

2.1

57.9

716

3555

NGF35

NOMESCO Finland

Plastic operation of joint cartilage of knee

3.0

57.7

353

1206

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.5

57.7

2035

14056

SPAT1254

SPAT

Administration of medicine

1.7

57.6

1289

7891

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

2.0

57.5

843

4475

SPAT1260

SPAT

Consultation of another employee

1.6

57.2

1626

10640

R50.9

ICD-10 Finland

Fever, unspecified

1.7

57.1

1217

7341

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.8

56.9

1105

6472

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.8

56.8

1087

6334

Z00.0

ICD-10 Finland

General medical examination

1.6

56.8

1639

10767

C08CA01

ATC

amlodipine; oral

1.4

56.7

3343

25715

R35

ICD-10 Finland

Polyuria

2.3

56.6

567

2561

J31.0

ICD-10 Finland

Chronic rhinitis

2.1

56.6

711

3551

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

3.3

56.4

294

897

KMAK

NOMESCO Finland

1.4

56.3

4883

40242

7263A

ICD-9 Finland

Peripheral enthesopathies and allied syndromes, Enthesopathy of elbow region[EPICONDYLITIS LATERALIS HUMERI]

+∞

56.3

G43.9

ICD-10 Finland

Migraine, unspecified

2.5

56.3

463

1891

A03

ICPC

Fever

1.7

56.2

1306

8083

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

4.0

56.1

237

608

R20.2

ICD-10 Finland

Paraesthesia of skin

2.2

56.1

584

2687

J05AB01

ATC

aciclovir; systemic

1.6

55.9

1914

13111

S21

ICPC

Skin texture symptom/complaint

1.8

55.9

1112

6563

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.8

55.9

372

1343

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

3.0

55.8

346

1192

G55.1*M51.1

ICD-10 Finland

Compression of nerve roots and nerve plexus in disc diseases in the lumbar region and other regions

3.6

55.8

265

752

NFB30

NOMESCO Finland

Primary total prosthetic replacement of hip joint not using cement

2.1

55.7

660

3215

N05CD07

ATC

temazepam; oral

1.8

55.7

1151

6874

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

2.4

55.7

499

2131

N06AA10

ATC

nortriptyline; systemic

4.0

55.7

235

603

M09AX01

ATC

hyaluronic acid; parenteral

2.5

55.6

478

1998

K07.60

ICD-10 Finland

Snapping jaw

2.6

55.5

426

1674

S22.3

ICD-10 Finland

Fracture of rib

2.2

55.5

606

2847

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

2.3

55.4

560

2539

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

2.9

55.3

359

1276

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.9

55.2

894

4923

M51.8

ICD-10 Finland

Other specified intervertebral disc disorders

5.8

55.2

162

284

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.7

55.1

1225

7475

M75.5

ICD-10 Finland

Bursitis of shoulder

4.2

55.1

217

522

M19.8

ICD-10 Finland

Other specified arthrosis

3.1

55.1

322

1064

N05AH04

ATC

quetiapine; oral

1.7

55.1

1412

8979

ZZH21

NOMESCO Finland

Graft of patients own bone, small pieces

3.7

54.9

250

685

SPAT1310

SPAT

Counselling related to known health issue

1.4

54.7

2893

21758

C10AA05

ATC

atorvastatin; oral

1.4

54.7

3546

27722

N17

ICPC

Vertigo/dizziness

1.8

54.7

969

5504

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.2

54.6

568

2610

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.8

54.5

1037

6028

NCL99

NOMESCO Finland

Other operation on muscle or tendon of elbow or forearm

58.5

54.5

A11

ICPC

Chest pain NOS

2.1

54.4

680

3390

M21.4

ICD-10 Finland

Flat foot [pes planus] (acquired)

3.3

54.3

289

895

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.5

54.2

1922

13267

G57.1

ICD-10 Finland

Meralgia paraesthetica

5.0

53.9

179

362

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.5

53.9

2148

15227

M79.9

ICD-10 Finland

Soft tissue disorder, unspecified

11.3

53.9

103

D07AD01

ATC

clobetasol; topical

1.6

53.8

1474

9535

R13

ICD-10 Finland

Dysphagia

2.2

53.6

573

2667

J01DA06

ATC

[U] cefuroxime; systemic

1.7

53.4

1341

8470

R06AX22

ATC

ebastine; oral

1.6

53.3

1557

10242

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.6

53.1

1440

9290

L88

ICPC

Rheumatoid/seropositive arthritis

2.7

53.1

381

1440

SHA02

NOMESCO Finland

Correction of physiology of bite - basic therapy visit

2.2

53.1

565

2625

L04AA13

ATC

leflunomide; oral

3.3

53.0

285

890

N02AJ13

ATC

tramadol and paracetamol; systemic

4.0

53.0

221

561

L01BA01

ATC

methotrexate; systemic (folic acid analog.)

2.6

53.0

409

1612

WX204

NOMESCO Finland

Axillary plexus blockaced

3.2

52.8

294

942

L05

ICPC

Flank/axilla symptom/complaint

2.3

52.6

494

2162

M66.0

ICD-10 Finland

Rupture of popliteal cyst

11.2

52.6

101

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.7

52.5

1179

7212

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.5

52.3

2109

14970

S83.2

ICD-10 Finland

Tear of meniscus, current

2.1

52.1

633

3115

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.2

51.7

572

2701

R60.9

ICD-10 Finland

Oedema, unspecified

2.5

51.7

441

1837

M23.8

ICD-10 Finland

Other internal derangements of knee

2.8

51.7

343

1236

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.2

51.6

542

2500

M77.2

ICD-10 Finland

Periarthritis of wrist

23.3

51.3

R03BA08

ATC

ciclesonide; inhalant

2.0

51.3

748

3957

QCB10

NOMESCO Finland

Major dressing of wound of skin of upper limb

3.6

51.1

244

695

M18.1

ICD-10 Finland

Other primary arthrosis of first carpometacarpal joint

4.4

51.1

194

451

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

3.4

51.1

262

790

M10.0

ICD-10 Finland

Idiopathic gout

3.0

51.1

314

1077

S97

ICPC

Chronic ulcer skin

2.3

50.9

501

2244

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.6

50.7

1315

8377

F51.0

ICD-10 Finland

Nonorganic insomnia

1.7

50.5

1099

6656

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.5

50.2

1752

12020

WX203

NOMESCO Finland

Infraclavicular plexus blockade

3.5

50.2

246

716

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.6

50.2

1315

8397

E000001

ATC

1.5

50.2

1817

12578

NDG60

NOMESCO Finland

Arthroplasty of first CMC joint

5.1

50.1

163

323

7290A

ICD-9 Finland

Other disorders of soft tissues, Rheumatism, unspecified and fibrositis

+∞

50.0

M76.3

ICD-10 Finland

Iliotibial band syndrome

13.4

50.0

R52.1

ICD-10 Finland

Chronic intractable pain

7.6

49.9

119

157

NHG80

NOMESCO Finland

Fusion of first tarsometatarsal joint

2.7

49.9

354

1330

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.7

49.6

1187

7386

SPAT1211

SPAT

Application of soft bandage

1.9

49.6

795

4356

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.6

49.5

378

1482

J01MA06

ATC

norfloxacin; oral

1.7

49.3

1249

7898

Z00.8

ICD-10 Finland

Other general examinations

2.0

49.2

630

3170

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.5

49.2

2193

15880

A01AB09

ATC

miconazole; local oral

1.9

49.1

806

4451

E66.8

ICD-10 Finland

Other obesity

2.3

49.1

465

2043

SPAT1202

SPAT

Intra-articular injection

2.8

49.1

331

1204

XF402

NOMESCO Finland

ECG with work load test

1.7

49.0

1017

6070

9476

FHL

Splitting of fascia or aponeurosis

11.9

48.9

NHM20

NOMESCO Finland

Excision of synovial ganglion of ankle or foot

9.3

48.6

103

112

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.4

48.6

2404

17772

R11

ICD-10 Finland

Nausea and vomiting

2.0

48.6

670

3471

S01GX01

ATC

cromoglicic acid; ophthalmic

1.5

48.4

1726

11890

R07.0

ICD-10 Finland

Pain in throat

2.2

48.3

527

2476

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.5

48.0

1855

13017

XKD00

NOMESCO Finland

Uroflowmetry

1.6

47.5

1284

8262

R12

ICD-10 Finland

Heartburn

2.0

47.4

612

3086

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.1

47.4

574

2819

R55

ICD-10 Finland

Syncope and collapse

1.8

47.1

931

5469

M67.0

ICD-10 Finland

Short Achilles tendon (acquired)

67.7

47.1

SHA01

NOMESCO Finland

Correction of physiology of bite - simple therapy visit

1.8

47.0

876

5048

A07AA02

ATC

nystatin; oral

2.1

47.0

582

2885

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.7

46.8

1070

6568

D19

ICPC

Teeth/gum symptom/complaint

1.4

46.7

2290

16875

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.6

46.7

1558

10563

H92.0

ICD-10 Finland

Otalgia

2.3

46.7

437

1907

U01

ICPC

Dysuria/painful urination

2.0

46.7

640

3305

L09

ICPC

Arm symptom/complaint

2.5

46.6

379

1537

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.6

46.5

1297

8408

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

2.2

46.5

514

2428

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

3.1

46.5

273

907

SPAT1283

SPAT

Restricted health certificate

1.6

46.5

1310

8517

C10AX09

ATC

ezetimibe; oral

1.7

46.4

963

5742

G57.6

ICD-10 Finland

Lesion of plantar nerve

3.8

46.4

201

529

J01CA08

ATC

pivmecillinam; oral

1.4

46.3

3567

28513

ABD30

NOMESCO Finland

Implantation of spinal stimulation device

8.2

46.1

105

129

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.9

46.1

705

3796

M01AE52

ATC

naproxen and esomeprazole; oral

2.7

46.1

330

1246

NHU20

NOMESCO Finland

Removal of internal fixation device from ankle or foot

2.4

46.0

395

1651

S01

ICPC

Pain/tenderness of skin

2.5

46.0

392

1632

R03AC13

ATC

formoterol; inhalant

2.3

46.0

460

2075

-1

NOMESCO Finland

1.4

46.0

2916

22540

A03CA02

ATC

clidinium and psycholeptics; oral

2.1

45.9

556

2729

M00.9

ICD-10 Finland

Pyogenic arthritis, unspecified

5.0

45.9

153

312

B01AF01

ATC

rivaroxaban; oral

1.7

45.8

1047

6423

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

2.8

45.7

303

1092

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

3.1

45.6

258

837

J01FA15

ATC

telithromycin; oral

1.7

45.4

930

5521

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.9

45.4

681

3642

C07AA05

ATC

propranolol; systemic

1.5

45.3

1686

11713

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.4

45.2

2460

18484

L20

ICPC

Joint symptom/complaint NOS

2.7

45.1

324

1225

NG1CG

NOMESCO Finland

Knee and lower leg extensive MRI examination with high intensity magnet

3.5

45.1

216

618

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.4

45.0

3862

31381

NF1DA

NOMESCO Finland

X-ray of hips

3.3

45.0

233

708

J46

ICD-10 Finland

Status asthmaticus

3.0

44.8

268

904

H53.1

ICD-10 Finland

Subjective visual disturbances

2.1

44.7

549

2712

J01CF05

ATC

flucloxacillin; systemic

2.5

44.6

368

1506

C10AA07

ATC

rosuvastatin; oral

1.4

44.6

2203

16237

N39.3

ICD-10 Finland

Stress incontinence

1.9

44.4

657

3492

J01MA14

ATC

moxifloxacin; systemic

1.8

44.4

801

4566

C10AA01

ATC

simvastatin; oral

1.3

44.4

3945

32218

C05AA08

ATC

fluocortolone; rectal, topical

1.6

44.2

1306

8585

M15.8

ICD-10 Finland

Other polyarthrosis

4.0

44.2

182

458

NHM10

NOMESCO Finland

Fasciotomy of ankle or foot

37.5

44.0

G04CA02

ATC

tamsulosin; oral

1.5

43.5

1701

11936

S83.6

ICD-10 Finland

Sprain and strain of other and unspecified parts of knee

2.3

43.4

423

1884

Z02.7

ICD-10 Finland

Issue of medical certificate

2.1

43.3

535

2650

M35.3

ICD-10 Finland

Polymyalgia rheumatica

2.5

43.3

350

1417

S15

ICPC

Foreign body in skin

2.0

43.2

548

2744

Z09.0

ICD-10 Finland

Follow-up examination after surgery for other conditions

1.9

43.1

707

3901

N06AB03

ATC

fluoxetine; oral

1.6

43.0

1118

7105

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.7

42.8

1063

6671

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.7

42.8

1064

6681

R51.81

ICD-10 Finland

Facial pain NOS

3.4

42.6

215

641

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.0

42.6

600

3128

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.7

42.5

879

5229

K59.0

ICD-10 Finland

Constipation

2.2

42.5

468

2204

SDA01

NOMESCO Finland

Simple parodonthologic therapy

1.4

42.4

2154

15940

L04

ICPC

Chest symptom/complaint

2.1

42.4

499

2421

NHG77

NOMESCO Finland

Arthroplasty of interphalangeal tarsal joint(s)

3.2

42.4

236

757

R4110

SPAT

2.8

42.3

278

996

B01AC04

ATC

clopidogrel; oral

1.6

42.3

1280

8458

S61.0

ICD-10 Finland

Open wound of finger(s) without damage to nail

1.8

42.2

753

4272

D07AA02

ATC

hydrocortisone; topical

1.6

42.2

1138

7302

S70.0

ICD-10 Finland

Contusion of hip

2.7

42.2

303

1146

M51.9

ICD-10 Finland

Intervertebral disc disorder, unspecified

4.3

42.1

161

378

R51

ICD-10 Finland

Headache

2.3

42.1

423

1911

A29

ICPC

General symptom/complaint other

1.7

42.1

952

5820

L18

ICPC

Muscle pain

2.6

42.0

321

1259

SPAT1325

SPAT

Vaccination

1.4

42.0

3042

23979

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.9

41.9

265

927

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

2.1

41.9

476

2276

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.0

41.8

582

3022

L84

ICPC

Back syndrome without radiat pain

2.3

41.8

394

1727

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

2.7

41.7

292

1088

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

2.3

41.6

404

1797

M01AG02

ATC

tolfenamic acid; oral, rectal

1.6

41.6

1345

9030

K10.3

ICD-10 Finland

Alveolitis of jaws

2.4

41.6

369

1569

G04BD08

ATC

solifenacin; oral

2.0

41.5

590

3089

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.6

41.5

310

1200

M25.2

ICD-10 Finland

Flail joint

5.9

41.3

119

205

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.5

41.1

1522

10541

NF1BA

NOMESCO Finland

Hip extensive X-ray examination

2.6

41.0

321

1276

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.9

41.0

264

932

H57.1

ICD-10 Finland

Ocular pain

2.8

40.9

282

1039

NH1CG

NOMESCO Finland

Ankle and foot extensive MRI examination with high intensity magnet

4.9

40.8

136

278

R00.2

ICD-10 Finland

Palpitations

1.9

40.8

600

3182

J02AC02

ATC

itraconazole; systemic

1.5

40.6

1629

11482

NG1AE

NOMESCO Finland

Knee joint ultrasound exmination

5.0

40.6

134

271

R06.5

ICD-10 Finland

Mouth breathing

1.8

40.5

755

4346

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

2.7

40.3

279

1032

M75

ICD-10 Finland

Shoulder lesions

2.4

40.3

361

1543

R06AE09

ATC

levocetirizine; oral

1.6

40.1

1227

8125

NF2AT

NOMESCO Finland

Injection to hip joint with ultrasound guidance

9.1

39.9

XF600

NOMESCO Finland

Bloodpressure measurement

2.0

39.8

532

2719

R25.2

ICD-10 Finland

Cramp and spasm

3.2

39.7

215

677

A08

ICPC

Swelling

2.3

39.6

376

1652

R75

ICPC

Sinusitis acute/chronic

2.3

39.5

379

1677

NDL52

NOMESCO Finland

Tenosynovectomy of hand

8.6

39.5

102

M24.2

ICD-10 Finland

Disorder of ligament

4.5

39.4

144

324

S20.2

ICD-10 Finland

Contusion of thorax

2.2

39.4

422

1966

H03AA01

ATC

levothyroxine sodium; systemic

1.4

39.3

2107

15723

N06AB10

ATC

escitalopram; oral

1.5

39.2

1645

11691

A97

ICPC

No disease

1.6

39.2

1248

8337

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

2.0

39.2

532

2738

S40.0

ICD-10 Finland

Contusion of shoulder and upper arm

2.5

39.1

332

1379

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.5

39.1

1393

9556

WZA00

NOMESCO Finland

Short statement of of health and health related matters

2.0

39.0

509

2575

S60.2

ICD-10 Finland

Contusion of other parts of wrist and hand

2.3

39.0

373

1648

H02.3

ICD-10 Finland

Blepharochalasis

2.0

38.8

556

2919

SPAT1058

SPAT

PEF monitoring instruction

1.8

38.8

709

4056

J01CF02

ATC

cloxacillin; systemic

2.9

38.7

246

863

J01

ICD-10 Finland

Acute sinusitis

2.2

38.7

412

1913

ABC16

NOMESCO Finland

Microsurgical excision of lumbar intervertebral disc displacement

2.5

38.7

319

1304

XQ800

NOMESCO Finland

Prick test

1.9

38.6

610

3322

M24.8

ICD-10 Finland

Other specific joint derangements, not elsewhere classified

7.5

38.5

123

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.2

38.5

400

1837

P06

ICPC

Sleep disturbance

1.7

38.2

803

4795

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.3

38.2

4092

34133

UJF30

NOMESCO Finland

Ileoscopy through colon

1.7

38.1

809

4846

R06.2

ICD-10 Finland

Wheezing

2.3

38.0

374

1676

A99

ICPC

Disease/condition unspecnature/site

1.8

38.0

680

3864

WX120

NOMESCO Finland

Intravenous local anesthesy of arm

4.4

37.9

141

323

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.9

37.9

585

3157

M18.0

ICD-10 Finland

Primary arthrosis of first carpometacarpal joints, bilateral

4.2

37.8

149

361

K29.3

ICD-10 Finland

Chronic superficial gastritis

2.5

37.8

299

1197

C09CA06

ATC

candesartan; oral

1.4

37.7

1927

14232

TNX32

NOMESCO Finland

Custom moulded splint, unspecified region

2.2

37.7

417

1969

C01DA14

ATC

isosorbide mononitrate; oral

1.6

37.7

1135

7478

ND1AA

NOMESCO Finland

Wrist X-ray examination

2.0

37.7

518

2678

A01AB04

ATC

amphotericin B; local oral

2.1

37.6

445

2164

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.3

37.6

3009

24013

L60.0

ICD-10 Finland

Ingrowing nail

2.3

37.5

360

1592

R06AX13

ATC

loratadine; oral

1.5

37.5

1287

8745

G04BD04

ATC

oxybutynin; oral, transdermal

2.1

37.5

465

2306

7260A

ICD-9 Finland

Peripheral enthesopathies and allied syndromes, Adhesive capsulitis of shoulder

+∞

37.5

B01AA03

ATC

warfarin; systemic

1.5

37.5

1589

11310

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.2

37.4

388

1779

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.7

37.4

261

969

R03AC12

ATC

salmeterol; inhalant

2.2

37.4

381

1734

F45.8

ICD-10 Finland

Other somatoform disorders

2.0

37.4

512

2642

N03AF01

ATC

carbamazepine; oral, rectal

2.1

37.4

459

2265

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.8

37.3

683

3904

N62

ICD-10 Finland

Hypertrophy of breast

2.3

37.3

360

1595

Z01.7

ICD-10 Finland

Laboratory examination

1.6

37.1

973

6184

M17.3

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3042936) Bacteria identified in Isolate by Culture

2878

12832

2.61

307.65

2.2

1.9

—

(3013707) Erythrocyte sedimentation rate by Westergren method

9735

73535

2.41

307.65

5.4

3.7

12.5

12.4

mm/h

0.11

9166

67649

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

3063

13668

2.64

307.65

1.4

1.2

11.0

13.5

u/ml

0.99

1134

5296

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

3140

14638

2.52

307.65

1.4

1.2

32.2

39.1

iu/ml

1.26

978

4692

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

3536

19400

2.14

290.21

2.0

1.7

1.1

1.3

mg/l

4.11

2746

14852

(3000475) Leukocytes [#/volume] in Synovial fluid

742

1738

4.47

288.92

1.6

18214.9

14838.0

e6/l

0.63

510

1263

(3013115) Eosinophils [#/volume] in Blood

7165

50607

1.96

286.09

6.9

6.0

0.2

e9/l

1.11

6293

44000

(3006315) Basophils [#/volume] in Blood

6968

48997

1.94

279.14

6.7

5.8

0.0

e9/l

1.70

6041

41964

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

4627

28466

1.99

274.37

2.4

2.0

187.3

218.4

u/l

1.51

4416

26557

(3001604) Monocytes [#/volume] in Blood

6918

48771

1.92

272.27

6.7

5.8

0.6

e9/l

0.11

6008

41760

(3019198) Lymphocytes [#/volume] in Blood

7059

50226

1.92

268.68

6.8

5.8

1.9

e9/l

0.33

6221

43805

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

9807

78393

2.12

261.80

8.4

7.4

76.7

79.0

u/l

5.50

9346

73625

(3026493) Urate [Moles/volume] in Serum or Plasma

4174

25334

1.97

252.83

2.8

2.6

2807.3

5141.3

umol/l

4.10

3586

21979

(3013826) Glucose [Moles/volume] in Serum or Plasma

7802

58008

1.90

252.19

5.4

4.5

6.7

mmol/l

1.66

7432

54119

(3013650) Neutrophils [#/volume] in Blood by Automated count

7738

57498

1.89

249.18

9.0

9.4

4.2

4.1

e9/l

2.71

6769

49909

(3031040) Bacteria [#/volume] in Urine by Automated count

8469

64799

1.93

249.14

5.8

4.1

1940.4

1835.9

e6/l

0.03

982

(3037467) Urinalysis macro (dipstick) panel - Urine

8764

68208

1.93

239.86

5.5

4.0

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

6858

49717

1.83

231.60

7.3

6.5

1.2

mmol/l

1.66

5954

41582

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

737

2024

3.80

230.46

1.4

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

11697

102510

2.87

223.14

20.2

12.9

22.6

24.7

mg/l

9.92

10007

79681

(3021788) Differential panel - Synovial fluid

566

1329

4.41

218.96

1.5

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

6268

44855

1.79

214.79

6.5

5.8

1.2

mmol/l

0.05

5729

40473

(3037522) Nuclear Ab [Titer] in Serum

2315

11947

2.15

214.30

1.4

1.3

490.8

540.1

titre

0.64

476

2553

(3044941) Cell count panel - Synovial fluid

503

1123

4.62

207.27

1.4

—

(3023368) Bacteria identified in Blood by Culture

4089

25969

1.85

206.58

4.7

4.2

—

(3006504) Eosinophils/100 leukocytes in Blood

6356

46071

1.76

204.72

7.0

6.0

2.9

2.8

0.48

5961

42833

(3022096) Basophils/100 leukocytes in Blood

6198

44657

1.76

203.38

7.0

6.0

0.7

0.57

5796

41567

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

6987

52094

1.76

203.28

5.8

6.5

10.5

11.6

umol/l

15.57

6654

49403

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

4582

30244

1.81

203.21

2.9

2.5

57.2

59.9

u/l

1.62

4251

27765

(3007853) Bacteria identified in Skin by Aerobe culture

2108

10701

2.16

202.50

2.0

1.7

—

(3019069) Monocytes/100 leukocytes in Blood

6374

46336

1.76

202.32

7.4

6.2

8.6

8.7

1.03

5986

43303

(42870588) Differential panel, method unspecified - Blood

4916

33169

1.79

202.18

6.7

5.9

—

(3002030) Lymphocytes/100 leukocytes in Blood

6498

47601

1.75

199.79

7.1

6.0

27.6

27.8

0.49

6079

44240

(3018010) Neutrophils/100 leukocytes in Blood

6407

46841

1.75

197.53

6.9

5.8

57.4

0.05

6017

43727

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

5650

40237

1.73

188.17

2.2

1.9

97.3

96.0

pmol/l

1.19

2941

20695

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

5224

36783

1.72

178.33

4.3

3.3

57.3

63.3

ng/l

0.14

3688

24773

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

6240

46112

1.70

177.84

4.4

3.8

—

(3035350) Ketones [Presence] in Urine by Test strip

6456

48187

1.69

176.84

4.4

3.4

0.0

estimate

1.28

1021

8786

(3021601) Nitrite [Presence] in Urine by Test strip

6460

48448

1.68

171.84

6.0

4.6

0.0

estimate

1.34

1067

8958

(3009261) Glucose [Presence] in Urine by Test strip

6511

48959

1.68

171.23

4.5

3.4

0.0

estimate

1.04

1048

8745

(3018095) Leukocytes [#/volume] in Urine

4936

34589

1.70

168.84

4.6

3.5

77.6

104.4

e6/l

1.78

3650

24002

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

5583

40925

1.65

157.20

2.5

2.2

78.1

77.8

nmol/l

0.33

5037

36639

(3032080) INR in Blood by Coagulation assay

5458

39856

1.65

155.46

9.5

8.6

1.2

1.3

inr

1.02

1456

11331

(3030467) Casts [#/volume] in Urine by Automated count

4000

27010

1.70

153.43

3.8

3.0

0.4

0.5

e6/l

1.38

3093

19936

(3011397) Hemoglobin [Presence] in Urine by Test strip

3443

22376

1.74

151.42

4.3

3.4

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

11813

107242

2.53

151.02

21.6

15.0

139.6

139.7

mmol/l

2.56

11651

104321

(3024561) Albumin [Mass/volume] in Serum or Plasma

5819

43427

1.63

150.14

5.0

4.8

35.6

35.5

g/l

0.80

5407

40247

(3001122) Ferritin [Mass/volume] in Serum or Plasma

5532

40799

1.63

149.55

3.2

2.7

123.4

139.7

ug/l

5.31

5131

37688

(36304419) Bacteria [Presence] in Urine

3886

26189

1.70

149.27

3.7

2.9

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

11830

107598

2.53

148.22

21.7

15.2

4.0

mmol/l

7.15

11654

104475

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

4032

27482

1.69

148.20

3.3

2.9

1275.7

1376.4

ng/l

0.75

3507

23524

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

10733

94159

1.92

147.23

5.6

4.5

2.2

mu/l

0.05

10014

85848

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

9254

77849

1.70

145.23

4.6

3.9

14.8

pmol/l

1.16

8520

70630

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

2957

18591

1.77

145.09

4.4

3.5

453.4

567.1

ng/l

0.45

2256

14542

(3002582) Erythrocytes [#/volume] in Urine

4235

29487

1.66

142.00

3.9

3.0

40.6

105.9

e6/l

6.10

3352

22194

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

3513

23294

1.70

141.93

2.5

2.2

2.9

3.0

mg/l

1.96

3051

19728

(3026008) Bacteria identified in Urine by Culture

4200

29200

1.66

141.54

3.8

2.9

—

(3000850) Epithelial cells [#/volume] in Urine

3099

19996

1.73

137.62

3.0

2.5

5.4

5.6

e6/l

0.36

2780

17420

(3018418) pH of Serum or Plasma

4204

29417

1.64

137.07

4.3

4.0

7.4

0.04

666

5689

(3044640) Blood type and Crossmatch panel - Blood

4404

31272

1.63

134.81

2.6

2.3

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

7605

61591

1.59

131.88

3.1

2.7

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

2453

14964

1.79

131.75

2.0

1.8

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

2645

16537

1.76

130.37

3.1

2.6

1.2

1.4

e6/l

0.28

1550

9166

(3019150) Specific gravity of Urine by Refractometry

3100

20503

1.68

123.42

4.9

3.8

1.0

kg/l

0.15

483

3096

(40768797) Stomach Pathology biopsy report

2173

13081

1.80

120.92

1.3

1.2

—

(3007164) IgA [Mass/volume] in Serum or Plasma

2734

17639

1.70

118.84

1.5

2.4

2.5

g/l

1.38

1631

10692

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

3004

19941

1.66

116.91

1.3

1.2

1.4

1.9

u/ml

1.97

790

5321

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1763

10160

1.85

112.44

1.9

1.7

—

(40758558) Short blood count panel - Blood

3609

25270

1.60

112.42

6.6

7.2

—

(3048689) Calprotectin [Mass/mass] in Stool

1849

10834

1.83

111.71

2.2

2.3

122.6

139.2

ug/g

1.33

1459

8494

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

3403

23641

1.60

108.90

2.5

2.3

—

(40761511) CBC panel - Blood by Automated count

11705

107975

2.12

108.06

17.6

12.3

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

10683

95750

1.74

107.84

6.5

5.5

40.1

39.7

mmol/mol

5.28

9999

88270

(3021960) Folate [Moles/volume] in Serum or Plasma

3232

22224

1.61

107.74

1.6

1.5

21.4

20.5

nmol/l

1.38

2773

18908

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

336

913

3.75

106.01

1.5

60.5

59.7

0.12

211

573

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1743

10186

1.82

105.76

1.9

1.7

—

(3033658) Prothrombin time (PT) actual/Normal

3616

25697

1.57

104.07

4.3

3.8

92.3

90.6

3.91

3520

25072

(3010144) Erythrocytes [#/volume] in Synovial fluid

276

663

4.23

103.28

1.4

169938.4

128803.9

e6/l

0.33

190

451

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

4399

32731

1.53

102.45

3.3

3.2

34.3

34.9

u/l

0.10

4186

30975

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

8045

67891

1.51

100.62

3.6

3.0

51.1

49.3

u/l

0.89

7537

63153

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

2386

15455

1.67

99.93

3.4

2.8

2.7

e6/l

0.18

1292

8153

(3008898) HLA-B27 [Presence]

617

2476

2.57

99.11

1.1

1.0

—

(3000494) Fungus identified in Specimen by Culture

1861

11294

1.76

98.85

1.6

1.4

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

11927

111450

2.23

96.18

12.9

9.9

26.6

26.5

u/l

0.19

11628

107283

(3015171) Extractable nuclear Ab [Units/volume] in Serum

739

3275

2.33

95.49

1.3

1.2

0.6

1.2

u/ml

0.77

241

(3022948) Iron [Moles/volume] in Serum or Plasma

2310

15040

1.66

94.17

2.8

2.4

12.8

13.1

umol/l

1.26

2134

13930

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1244

6775

1.93

93.45

1.7

1.6

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

4481

33974

1.49

92.94

3.1

3.6

2.4

mmol/l

2.08

3886

29615

(3044889) 12 lead EKG panel

8478

72889

1.49

92.19

4.2

3.6

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

1134

6065

1.96

89.73

2.4

2.3

21.4

25.7

au/ml

0.57

376

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

446

1598

2.86

89.38

1.7

1.5

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

11051

101149

1.73

88.83

5.1

4.4

6.0

5.9

mmol/l

2.92

10265

92126

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1433

8318

1.82

87.80

2.2

2.3

359.5

382.6

nmol/l

3.85

1325

7664

(3022217) INR in Platelet poor plasma by Coagulation assay

1951

12373

1.68

87.34

25.6

23.5

1.3

inr

0.03

275

1747

(3026782) Osmolality of Urine

2732

18825

1.58

87.30

3.1

2.6

530.9

547.6

mosm/kgh2o

3.92

2391

15977

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

10814

98523

1.67

87.01

17.0

12.5

80.4

80.5

ml/min/173m2

0.16

9200

80800

(3019309) Folate [Moles/volume] in Red Blood Cells

2601

17754

1.59

86.46

1.8

1.7

1162.0

1168.3

nmol/l

0.13

2018

13236

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

1043

5538

1.96

84.09

1.3

47.4

48.9

au/ml

0.07

267

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

4802

37453

1.45

83.71

4.8

3.6

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

2126

13928

1.63

83.46

2.8

2.4

2.3

g/l

0.03

1957

12863

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1770

11119

1.69

81.66

6.9

7.4

5.1

kpa

1.20

1696

10628

(3027801) Oxygen [Partial pressure] in Arterial blood

1769

11114

1.69

81.57

6.9

7.4

12.0

12.6

kpa

6.11

1693

10615

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

2266

15156

1.60

81.49

1.6

1.4

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1504

9075

1.75

80.28

2.6

2.4

49.2

42.8

u/l

0.24

1255

7763

(3012095) Magnesium [Moles/volume] in Serum or Plasma

2348

15932

1.58

79.17

3.2

3.5

0.8

mmol/l

0.92

2195

14881

(3018677) aPTT in Platelet poor plasma by Coagulation assay

2229

14945

1.60

79.08

2.2

2.0

29.7

29.8

0.19

2158

14520

(3003396) Base excess in Arterial blood by calculation

1753

11117

1.67

77.70

6.9

7.4

1.1

1.0

mmol/l

0.11

1414

8784

(3007461) Platelets [#/volume] in Blood

12206

116148

2.45

77.37

28.3

19.2

253.2

251.4

e9/l

2.46

11992

112708

(3035941) MCH [Entitic mass]

12207

116221

2.43

76.23

28.1

19.1

30.4

30.3

3.78

12116

114370

(3010813) Leukocytes [#/volume] in Blood

12210

116265

2.44

76.17

28.3

19.3

6.8

6.6

e9/l

14.25

11978

112417

(3026361) Erythrocytes [#/volume] in Blood

12208

116251

2.43

75.91

28.3

19.2

4.5

e12/l

20.68

11978

112438

(3024731) MCV [Entitic volume]

12207

116239

2.43

75.88

28.2

19.2

91.4

91.1

11.66

12117

114384

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1980

13024

1.62

75.73

2.9

2.5

21.8

22.8

2.74

1676

11117

(3000963) Hemoglobin [Mass/volume] in Blood

12208

116291

2.42

75.14

28.4

19.3

134.6

135.8

g/l

15.61

12119

114445

(3005322) IgE [Units/volume] in Serum or Plasma

1012

5519

1.91

75.04

1.3

268.4

251.4

u/ml

0.17

943

5071

(3016502) Oxygen saturation in Arterial blood

1581

9851

1.69

74.71

7.2

7.9

95.7

0.02

1524

9482

(3021589) Normoblasts [#/volume] in Blood

5514

44768

1.41

74.03

10.5

9.3

0.0

e9/l

0.69

4493

36562

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

250

710

3.57

73.89

1.5

1.4

26.0

30.1

0.91

163

434

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

1217

7096

1.79

72.73

4.0

3.8

96.8

91.9

ng/l

0.57

1069

6089

(40761535) Cells panel - Urine sediment

1293

7682

1.76

72.44

4.2

3.4

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

1376

8372

1.72

70.75

6.9

7.1

1.3

mmol/l

0.93

1325

8072

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1732

11238

1.63

69.52

2.7

6.2

9.3

umol/l

12.84

1491

9771

(3004588) Protein electrophoresis panel - Serum or Plasma

1091

6261

1.81

68.58

2.2

2.4

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

568

2589

2.25

68.35

2.0

1.8

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

1854

12285

1.60

68.11

7.3

7.1

104.3

104.4

mmol/l

0.47

1821

12027

(3020630) Protein [Mass/volume] in Serum or Plasma

1275

7701

1.73

67.12

2.4

2.7

66.2

66.5

g/l

0.59

1144

6986

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1329

8121

1.71

67.07

2.4

2.2

7.3

8.0

ug/l

0.38

1134

7048

(3029937) Albumin [Presence] in Urine by Test strip

3417

25808

1.44

67.02

5.1

3.8

0.0

estimate

0.47

1035

8596

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

11321

105722

1.67

66.69

5.5

4.8

2.7

2.8

mmol/l

8.46

10566

97239

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

961

5373

1.85

65.65

1.8

1.6

—

(3012544) pH of Venous blood

1429

9055

1.65

62.58

4.2

3.7

7.4

—

(3009508) Creatinine [Moles/volume] in Urine

3992

31314

1.40

62.28

3.3

3.1

7.4

7.5

mmol/l

1.20

3385

26234

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1386

8732

1.66

62.05

4.2

3.7

5.9

5.8

kpa

1.77

1346

8481

(3002032) Base excess in Venous blood by calculation

1381

8701

1.66

61.80

4.2

3.7

1.9

mmol/l

0.09

1143

7072

(4010399)

1154

6955

1.73

60.95

1.5

1.4

—

(40760892) CBC W Ordered Manual Differential panel - Blood

2903

21587

1.45

60.84

5.0

4.5

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1433

9155

1.64

60.64

7.7

8.3

121.7

121.2

g/l

0.32

1389

8823

(3012516) Albumin [Mass/volume] in Urine

3804

29772

1.40

59.51

3.3

3.2

467.6

347.2

mg/l

0.79

2472

18345

(3020682) Albumin/Creatinine [Ratio] in Urine

3980

31390

1.39

59.46

4.0

3.9

10.4

8.1

mg/mmol

2.17

2545

19506

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1856

12666

1.55

59.20

6.2

5.7

1.0

mmol/l

0.95

1716

11808

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

11110

103812

1.58

58.84

4.9

4.3

4.7

mmol/l

7.73

10417

95984

(3027945) Reticulocytes/100 erythrocytes in Blood

1612

10724

1.58

57.43

2.5

1.8

0.28

1451

9472

(3019060) Gas panel - Arterial blood

1043

6231

1.73

56.70

4.5

5.0

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

513

2419

2.17

56.68

1.3

1.2

21.7

48.4

u/ml

1.56

156

(3002385) Erythrocyte distribution width [Ratio]

9457

85837

1.40

56.36

22.5

16.1

13.8

13.7

2.56

9338

83859

(3000991) Gas panel - Venous blood

1276

8084

1.64

55.55

8.3

8.4

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

725

3914

1.90

55.01

1.5

1.6

24.8

13.6

u/ml

0.50

114

(40768804) Tissue Pathology biopsy report

5078

42045

1.35

54.39

2.2

2.1

—

(3024354) Oxygen [Partial pressure] in Venous blood

1146

7100

1.68

54.37

3.5

3.0

4.7

4.6

kpa

0.36

1110

6864

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

11013

103048

1.53

54.15

4.9

4.3

1.5

mmol/l

6.15

10262

94768

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

1276

8137

1.63

54.05

3.1

2.8

189.4

202.1

ng/l

0.52

1154

7410

(3023520) Reticulocytes [#/volume] in Blood

1243

7892

1.64

53.56

2.4

2.6

69.8

70.2

e9/l

0.12

946

5947

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

2478

18314

1.44

52.53

2.8

3.2

2.4

2.5

mmol/l

2.05

2150

16017

(3005719) IgG [Mass/volume] in Serum or Plasma

1132

7073

1.66

51.88

2.7

2.8

10.2

10.6

g/l

3.35

1034

6460

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

469

2216

2.16

51.53

1.3

3.4

7.6

u/ml

2.75

370

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

655

3505

1.92

50.99

2.1

2.3

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

655

3506

1.92

50.95

2.1

2.3

7.3

7.4

g/l

0.35

482

2628

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

654

3503

1.91

50.76

2.1

2.3

3.7

3.9

g/l

1.48

458

2511

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

916

5439

1.74

50.71

1.6

1.5

—

(3024263) Appearance of Synovial fluid

148

382

3.91

50.37

1.6

1.8

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

10664

99472

1.46

49.77

4.3

3.9

1.4

1.3

mmol/l

15.75

9876

90809

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

549

2797

2.01

49.30

1.8

1.6

—

(3003338) MCHC [Mass/volume]

9633

88375

1.38

48.62

24.8

16.8

331.9

332.3

g/l

4.06

9592

87711

(3000492) Spirometry study

1389

9255

1.56

48.61

1.5

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

458

2194

2.13

48.57

1.3

3.5

6.1

u/ml

0.62

242

(3022145) Colonoscopy Study observation

1612

11107

1.52

48.38

1.3

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

970

5944

1.68

47.75

6.9

7.2

24.7

24.6

mmol/l

0.26

906

5540

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

762

4366

1.79

47.66

4.1

24.2

24.1

mmol/l

0.18

676

3937

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

519

2634

2.01

47.10

1.9

1.6

1.2

g/l

0.29

486

2489

(3013512) EKG study

3633

29066

1.35

47.00

4.4

3.7

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

507

2555

2.03

46.93

1.9

1.6

0.2

g/l

0.13

472

2401

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1611

11175

1.51

46.71

3.7

4.5

244.9

246.1

u/l

0.07

1502

10567

(3014765) Yersinia sp identified in Stool by Organism specific culture

518

2647

2.00

46.11

1.2

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

572

3031

1.93

45.81

2.4

2.2

363.9

707.0

ug/l

2.32

541

2844

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

513

2619

2.00

45.78

1.2

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

608

3292

1.89

45.61

2.1

2.3

9.7

10.4

g/l

3.28

511

2761

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

605

3284

1.88

45.02

2.2

2.3

3.1

g/l

0.36

467

2577

(42529406) Shigella sp [Presence] in Stool by Culture

516

2656

1.98

44.98

1.2

—

(36660697) Celiac disease serology panel - Serum

1114

7173

1.61

44.98

1.2

1.1

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

391

1831

2.17

43.95

1.3

1.2

2.0

4.7

u/ml

1.14

153

(3000570) Elastase.pancreatic [Mass/mass] in Stool

514

2669

1.97

43.69

1.4

304.3

264.9

ug/g

4.13

295

1593

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

733

4264

1.76

43.46

3.0

2.7

0.7

0.18

695

4093

(3013139) Helicobacter pylori Ag [Presence] in Stool

997

6306

1.63

43.25

1.3

1.2

—

(3003327) Ova and parasites identified in Stool by Light microscopy

556

2979

1.91

43.05

1.8

1.7

—

(3009542) Hematocrit [Volume Fraction] of Blood

10205

95022

1.38

42.98

20.4

14.2

39.9

0.02

7299

68600

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

553

2975

1.90

42.29

2.2

2.4

0.7

1.0

g/l

1.52

485

2534

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

755

4468

1.73

42.12

1.1

1.0

—

(3025941) Bacteria identified in Stool by Culture

852

5211

1.68

42.10

1.3

1.2

—

(3028026) IgM [Mass/volume] in Serum or Plasma

900

5586

1.66

42.03

1.8

2.0

1.4

g/l

0.14

816

5079

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

518

2735

1.93

41.91

1.5

1.6

2.6

8.7

iu/ml

0.54

130

596

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

929

5834

1.64

41.41

4.1

3.5

5.2

5.1

kpa

0.23

855

5396

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

500

2621

1.95

41.33

2.2

2.3

0.0

g/l

1.80

459

2382

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

966

6152

1.62

40.67

8.8

9.1

1.4

0.21

959

6109

(3014007) Fractional oxyhemoglobin in Arterial blood

964

6149

1.61

40.31

8.9

9.3

93.9

94.0

0.23

959

6128

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

373

1778

2.13

40.08

1.3

1.2

35.8

44.3

u/ml

0.45

176

(3009343) pH of Capillary blood

911

5756

1.63

39.58

4.1

3.5

7.4

0.01

107

755

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

3369

27311

1.32

38.10

1.7

1.6

1.5

1.4

mmol/l

6.13

2877

22844

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

814

5047

1.65

38.09

2.5

2.4

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

834

5210

1.64

37.88

8.7

9.5

24.4

mmol/l

0.32

768

4871

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

387

1914

2.05

37.72

1.4

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

387

1914

2.05

37.72

1.4

1.3

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

876

5546

1.62

37.71

4.1

3.4

1.7

1.8

mmol/l

0.56

658

4137

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

952

6150

1.59

37.69

9.0

9.2

0.7

0.05

945

6112

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

504

2736

1.88

37.46

2.1

2.2

38.0

37.6

g/l

0.70

434

2340

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

396

1984

2.03

37.25

1.4

—

(3004616) Nuclear Ab [Presence] in Serum

249

1034

2.44

37.15

1.4

1.3

—

(3020779) Urea [Moles/volume] in Serum or Plasma

1255

8649

1.50

37.03

8.3

7.2

9.8

9.7

mmol/l

0.14

1189

8256

(3017143) Hepatitis C virus Ab [Presence] in Serum

1430

10138

1.46

36.58

1.7

1.6

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1019

6740

1.56

36.37

2.0

1.8

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

162

4.90

36.18

1.3

1.2

32.5

37.1

0.46

113

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

129

381

3.41

36.09

1.7

1.4

5.1

6.0

u/l

1.40

107

325

(3013166) Neutrophils/100 leukocytes in Synovial fluid

202

4.43

36.04

1.4

61.3

55.2

0.72

170

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

459

2449

1.91

35.98

2.2

2.3

0.0

g/l

0.50

419

2219

(3004119) Hemoglobin [Mass/volume] in Venous blood

888

5718

1.59

35.58

3.5

3.2

129.1

128.8

g/l

0.17

873

5590

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

618

3624

1.74

35.55

1.1

0.9

10.6

u/ml

0.95

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

453

2417

1.91

35.51

2.2

2.3

0.0

g/l

0.00

419

2214

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

1173

8048

1.50

35.29

2.9

2.6

66.2

66.1

ml/min/173m2

0.03

500

3092

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

2653

20979

1.33

35.24

1.7

45737916.5

28218802.2

pmol/l

0.68

2217

17237

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

547

3106

1.80

35.15

1.6

133.3

316.5

titre

2.55

139

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1108

7557

1.51

34.26

2.1

1.9

—

(3045414) Leukocytes [Presence] in Urine

686

4194

1.67

33.83

2.0

1.8

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

483

2680

1.83

33.49

1.3

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

1884

14263

1.38

32.98

1.8

1.7

—

(3041096) Erythrocytes [Presence] in Urine by Automated

3212

26346

1.29

32.22

4.0

3.1

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

685

4244

1.65

32.06

1.7

1.6

g/l

0.05

595

3620

(3004716) Salmonella sp identified in Stool by Organism specific culture

719

4520

1.63

31.75

1.4

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

648

3978

1.66

31.43

2.0

39.5

39.2

u/l

0.13

573

3512

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

455

2534

1.83

31.18

1.6

1.4

17.0

17.2

iu/ml

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

618

3781

1.67

30.37

2.2

2.0

1.5

2.4

ug/l

1.05

542

3345

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

257

1202

2.16

29.08

6.0

6.2

11.7

mg/l

0.00

229

1103

(3034891) Synovial lining cells/100 cells in Synovial fluid

117

373

3.16

29.02

1.5

1.4

5.2

3.0

0.57

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1658

12543

1.37

28.83

8.0

6.6

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

799

5273

1.55

28.65

9.3

10.3

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

573

3501

1.67

28.30

1.7

—

(3019225) pH of Specimen

1339

9812

1.41

28.17

5.1

4.2

—

(3017732) Neutrophils [#/volume] in Blood

962

6632

1.49

28.05

3.1

2.9

4.0

4.1

e9/l

0.15

716

5111

(3052851) Hemolysis interference index of Serum or Plasma

488

2880

1.72

27.43

3.4

3.2

—

(3022313) Gas panel - Capillary blood

650

4151

1.60

26.87

4.3

3.6

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

501

3009

1.69

26.41

2.6

3.4

33.0

51.1

mg/l

2.80

421

2374

(3020961) Endomysium IgA Ab [Titer] in Serum

647

4146

1.59

26.36

1.1

65.0

223.9

titre

1.76

117

(3034860) Kappa light chains.free [Mass/volume] in Serum

501

3015

1.69

26.21

2.7

3.4

41.5

52.1

mg/l

2.94

421

2377

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

621

3950

1.60

26.10

2.2

1.9

—

(3020891) Body temperature

600

3797

1.61

25.76

5.3

4.6

—

(4034850)

527

3233

1.66

25.62

11.8

8.9

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

413

2374

1.76

25.49

1.2

1.1

—

(3024928) Oxygen saturation in Venous blood

349

1914

1.85

25.18

2.8

3.2

—

(3017181) Myelocytes/100 leukocytes in Blood

1146

8332

1.41

25.09

4.4

4.1

0.9

1.0

0.25

316

2426

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

873

6033

1.48

25.09

3.0

3.4

4.4

4.5

pmol/l

0.49

772

5359

(3043409) Potassium [Moles/volume] in Arterial blood

477

2880

1.68

24.66

4.6

4.2

3.9

mmol/l

0.80

461

2704

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

484

2934

1.68

24.64

2.6

3.4

1.7

5.6

ratio

0.77

191

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1531

11713

1.35

24.49

1.9

1.7

1.5

1.4

1.86

1332

10291

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

566

3581

1.61

24.32

4.6

3.8

24.8

24.9

mmol/l

0.40

512

3288

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

273

1397

1.98

24.31

1.5

1.4

—

(3036670) Protein [Mass/volume] in Synovial fluid

203

3.71

24.06

1.3

1.2

39.6

39.9

g/l

0.05

107

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

429

2538

1.71

23.92

1.4

1.3

—

(3018405) Lactate [Moles/volume] in Arterial blood

533

3339

1.62

23.85

4.3

3.9

1.4

mmol/l

0.02

525

3281

(3026389) Candida sp identified in Specimen by Organism specific culture

267

1365

1.98

23.85

1.5

1.3

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

229

1110

2.08

23.70

1.3

1.2

65.1

64.7

u/ml

0.01

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

647

4249

1.55

23.67

4.5

3.7

50.6

47.9

2.10

640

4204

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

566

3605

1.60

23.65

2.1

1.7

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

242

1206

2.03

23.24

1.4

1.5

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

236

1168

2.04

23.10

1.4

1.5

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

236

1169

2.04

23.05

1.4

1.5

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

750

5113

1.50

23.03

2.9

2.6

0.2

0.3

e6/l

3.81

727

4990

(3025468) Yersinia sp identified in Specimen by Organism specific culture

236

1171

2.03

22.94

1.4

1.5

—

(40768443) Skin Pathology biopsy report

661

4400

1.53

22.74

1.3

1.2

—

(3047181) Lactate [Moles/volume] in Blood

481

2976

1.64

22.64

5.2

6.4

1.3

mmol/l

0.53

433

2637

(3024522) Salmonella sp identified in Specimen by Organism specific culture

237

1186

2.02

22.51

1.4

1.5

—

(3019230) Fractional oxyhemoglobin in Venous blood

289

1556

1.88

22.15

2.4

2.8

61.4

65.4

2.24

289

1549

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1559

12135

1.32

22.02

1.6

—

(3025159) Blasts/100 leukocytes in Blood

1026

7488

1.40

21.89

4.4

4.1

0.1

0.3

1.51

246

1922

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

252

1303

1.95

21.82

1.3

1.2

2.8

3.8

u/ml

1.77

106

572

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

233

1175

2.00

21.68

1.4

1.5

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

120

460

2.62

21.37

1.5

1.2

435.0

411.9

u/l

0.04

107

423

(3021440) Promyelocytes/100 leukocytes in Blood

1073

7926

1.39

21.29

4.4

4.1

0.1

0.68

292

2256

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

424

2586

1.66

21.12

2.2

2.1

11.1

mg/l

0.04

392

2417

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

514

3289

1.59

21.08

2.8

2.6

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

835

5921

1.44

20.92

7.4

7.2

24.9

24.8

mmol/l

0.41

830

5860

(3035947) Staphylolysin Ab [Units/volume] in Serum

110

409

2.70

20.82

1.2

1.1

2.8

3.9

iu/ml

1.02

(3049717) Cytology report of Urine Cyto stain

544

3550

1.56

20.49

2.6

2.8

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

394

2377

1.68

20.47

3.0

2.9

24.8

24.9

mmol/l

0.05

347

2080

(3036489) Thrombin time

538

3510

1.56

20.28

2.1

2.0

21.1

21.6

1.37

468

3095

(3024891) Influenza virus A+B Ag [Presence] in Specimen

391

2361

1.68

20.25

1.2

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

144

617

2.35

20.25

1.2

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

144

617

2.35

20.25

1.2

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

144

618

2.35

20.18

1.2

1.1

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

227

1165

1.97

20.12

2.4

1.9

25.0

27.4

mg/l

0.27

304

(3027273) Bicarbonate [Moles/volume] in Venous blood

675

4634

1.48

20.01

4.1

3.2

25.4

25.2

mmol/l

0.85

654

4513

(3038026) Centromere Ab [Units/volume] in Serum

154

683

2.27

20.00

1.2

71.7

57.0

u/ml

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

142

613

2.33

19.65

1.2

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

142

613

2.33

19.65

1.2

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

142

613

2.33

19.65

1.2

1.1

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

3610

31393

1.21

19.39

4.8

4.7

2.3

3.2

ug/l

3.20

3269

28240

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

150

667

2.26

19.37

1.2

17.8

44.3

u/ml

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

509

3315

1.56

19.35

3.2

3.0

0.3

0.4

u/ml

0.46

288

1867

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

149

666

2.25

19.02

1.2

119.6

74.9

u/ml

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1244

9572

1.33

18.90

2.1

2.2

0.2

g/l

5.98

1156

8926

(3002179) Metamyelocytes/100 leukocytes in Blood

1015

7584

1.37

18.70

4.2

3.9

0.7

0.10

227

1761

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

586

3968

1.50

18.60

4.6

5.3

1.8

1.6

2.65

550

3723

(4306422)

241

1308

1.86

18.10

1.2

—

(40760888) Immunoglobulin light chains.free panel - Serum

370

2272

1.65

18.00

2.6

3.6

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1355

10622

1.31

17.99

1.6

—

(3014051) Protein [Presence] in Urine by Test strip

339

2042

1.68

17.77

2.3

2.1

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

326

1944

1.69

17.75

1.2

1.3

3.8

mmol/l

0.38

298

1832

(3024980) IgG subclass 4 [Mass/volume] in Serum

261

1462

1.80

17.70

1.5

1.6

0.7

0.9

g/l

1.79

212

1079

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

247

1362

1.83

17.64

1.3

1.2

1.8

4.2

u/ml

3.56

485

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

277

1581

1.77

17.64

1.1

1.6

1.4

u/ml

0.13

110

586

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

417

2653

1.59

17.57

2.7

2.3

187.2

194.9

0.99

392

2533

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

141

643

2.21

17.19

1.2

1.6

8.0

u/ml

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

254

1426

1.80

17.11

1.0

1.1

4.9

4.4

u/ml

0.21

126

669

(3007930) Methemoglobin/Hemoglobin.total in Blood

569

3899

1.48

17.05

4.7

5.4

0.9

0.38

535

3656

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

127

558

2.29

16.94

1.3

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

484

3212

1.53

16.92

1.8

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

168

829

2.04

16.72

1.5

1.7

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

241

1343

1.81

16.66

1.2

1.3

0.2

0.3

nmol/l

0.19

(3022621) pH of Urine by Test strip

846

6253

1.38

16.65

3.4

2.8

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

135

613

2.22

16.65

1.4

1.3

0.5

1.2

u/ml

1.19

282

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

126

556

2.28

16.64

1.3

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

240

1341

1.80

16.45

1.3

4.1

1.7

nmol/l

0.30

229

1279

(3011985) Renin [Units/volume] in Plasma

233

1292

1.82

16.38

1.5

94.7

57.3

mu/l

0.72

213

1139

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

586

4075

1.46

16.29

2.0

1.9

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

356

2224

1.62

16.21

1.3

490.8

558.0

mg/l

1.44

340

2110

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

839

6237

1.37

15.93

1.2

138.0

149.3

iu/ml

0.37

323

2405

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

235

1320

1.80

15.84

1.1

—

(4268621)

173

889

1.96

15.40

2.3

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

212

1167

1.83

15.29

1.2

1.3

—

nmol/l

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

316

1949

1.64

15.17

1.2

1.4

22.2

31.6

e6/l

0.32

238

1494

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

316

1951

1.64

15.11

1.3

1.4

969.6

1353.2

e6/l

0.39

254

1591

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

241

1386

1.75

15.02

1.1

19.5

12.5

au/ml

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

220

1238

1.79

14.78

1.4

29.8

32.6

u/l

0.56

181

1020

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

4.86

14.70

1.0

—

(3039000) Anion gap in Blood

334

2116

1.59

14.40

5.8

7.6

10.9

11.2

mmol/l

0.87

304

1901

(3018572) Chloride [Moles/volume] in Blood

334

2117

1.59

14.37

5.8

7.6

104.8

105.3

mmol/l

0.86

304

1902

(3023511) Choriogonadotropin [Units/volume] in Urine

186

1005

1.86

14.27

1.4

1.3

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

223

1275

1.76

14.21

1.2

1.1

125.1

117.5

2.37

201

1146

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

214

1209

1.78

14.20

1.3

278.2

277.1

pmol/l

0.02

178

939

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

2873

25047

1.19

14.15

4.3

4.0

22.4

21.9

1.00

1318

11958

(3044927) Protein electrophoresis panel - Urine

167

874

1.92

14.13

1.3

1.2

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1269

10170

1.28

14.07

3.8

3.2

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

373

2439

1.55

14.02

1.1

3.3

8.0

u/ml

2.26

321

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

293

1810

1.63

14.02

1.3

1.2

387.5

136.9

titre

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

236

1383

1.72

13.80

1.0

1.1

u/ml

0.03

540

(3017446) Testosterone [Moles/volume] in Serum or Plasma

911

7006

1.32

13.80

2.4

2.1

13.4

12.7

nmol/l

1.23

817

6257

(3024139) IgG subclass 3 [Mass/volume] in Serum

171

911

1.89

13.72

1.4

1.3

0.4

g/l

0.17

130

610

(3045424) Erythrocytes [Presence] in Urine

270

1643

1.66

13.71

1.6

1.5

—

(40757494) Bilirubin.total [Moles/volume] in Blood

108

487

2.23

13.64

1.9

2.3

19.2

34.4

umol/l

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

171

913

1.88

13.64

1.4

1.3

2.9

3.0

g/l

0.34

129

613

(3027135) IgG subclass 1 [Mass/volume] in Serum

171

913

1.88

13.64

1.4

1.3

6.5

7.1

g/l

1.24

130

611

(3047007) Chlamydophila sp Ab [Presence] in Serum

219

1270

1.74

13.31

1.2

—

(3028626) Oxygen [Partial pressure] in Capillary blood

322

2066

1.57

13.18

3.0

2.8

8.2

8.1

kpa

0.54

297

1912

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

168

903

1.87

13.14

3.7

3.8

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

212

1224

1.74

13.10

1.2

1.3

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

175

957

1.84

12.97

1.2

1.1

99.8

96.3

0.97

161

899

(4062490)

168

908

1.86

12.93

1.4

1.3

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

427

2924

1.48

12.91

2.3

2.1

94.6

90.7

3.00

399

2724

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

413

2814

1.48

12.80

2.5

3.7

3.6

g/l

0.27

398

2690

(3036071) Salmonella sp Ab [Titer] in Serum

234

2.74

12.68

1.1

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

219

1290

1.71

12.61

1.1

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

285

1797

1.60

12.59

1.2

—

(3007566) Smooth muscle Ab [Titer] in Serum

401

2729

1.48

12.52

1.2

116.6

149.6

titre

0.46

254

(3010726) Horse dander IgE Ab [Units/volume] in Serum

220

1301

1.70

12.49

1.0

1.1

1.2

1.8

u/ml

0.52

291

(3006184) Hemoglobin [Mass/volume] in Capillary blood

336

2207

1.54

12.42

2.3

2.2

132.0

129.8

g/l

0.88

249

1561

(3044290) Cell count panel - Cerebral spinal fluid

287

1820

1.59

12.38

1.2

1.4

—

(3000330) Specific gravity of Urine by Test strip

661

4931

1.36

12.30

3.8

3.4

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

438

2.22

12.26

1.4

1.6

6.6

8.3

ug/l

0.93

395

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

263

1642

1.61

12.12

1.6

—

(44813793)

123

614

2.01

12.00

1.1

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

259

1616

1.62

11.97

1.3

—

(3003181) Sodium [Moles/volume] in Urine

267

1680

1.60

11.92

1.4

61.3

63.3

mmol/l

0.34

225

1318

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

324

2142

1.53

11.65

1.6

—

(3035320) C reactive protein [Mass/volume] in Body fluid

129

662

1.96

11.65

3.0

2.2

—

(3023419) Bacteria identified in Sputum by Culture

202

1192

1.71

11.60

2.5

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

129

665

1.95

11.51

1.6

1.5

29.9

23.6

u/ml

0.76

136

(3023430) Cat dander IgE Ab [Units/volume] in Serum

185

1072

1.74

11.35

1.1

3.5

3.4

u/ml

0.05

392

(3011648) Oxygen content in Venous blood

135

711

1.91

11.31

2.0

2.1

10.5

11.3

1.35

135

711

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

166

940

1.78

11.04

1.0

0.2

0.7

u/ml

0.88

187

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

252

1596

1.59

10.99

1.1

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

282

1833

1.55

10.98

1.9

1.8

188.4

201.0

pmol/l

1.35

268

1741

(3021879) Hepatitis B virus core Ab [Presence] in Serum

844

6634

1.29

10.89

1.4

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

378

2.23

10.76

1.1

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

243

1537

1.59

10.67

1.2

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

355

2.26

10.60

2.6

1.5

123.5

134.9

umol/l

0.12

173

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

479

2.08

10.57

1.2

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

262

1691

1.56

10.55

1.5

1.4

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

136

736

1.86

10.52

1.6

1.9

9.2

9.4

umol/l

0.02

101

534

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

334

2279

1.48

10.36

1.6

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

176

1035

1.71

10.29

3.7

3.9

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

356

2464

1.46

10.27

1.3

214.3

218.5

miu/ml

0.08

156

1110

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

384

2700

1.44

10.19

1.3

—

(3021901) Oxygen saturation in Capillary blood

267

1752

1.54

10.01

3.1

2.8

—

(4094501)

392

2779

1.42

9.95

1.1

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

110

566

1.95

9.93

1.3

1.2

44.0

70.7

titre

—

(3011288) Drugs identified in Urine by Screen method

268

1765

1.53

9.88

2.5

3.2

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

190

1154

1.66

9.86

1.1

3.2

3.4

u/ml

0.05

414

(3006270) Folate [Moles/volume] in Blood

140

782

1.80

9.81

1.3

1.1

377.5

360.9

nmol/l

0.40

121

646

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

143

805

1.79

9.76

1.5

1.8

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

143

805

1.79

9.76

1.5

1.8

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

143

805

1.79

9.76

1.5

1.8

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

165

968

1.71

9.76

3.7

3.5

60.5

57.7

0.73

632

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

147

836

1.77

9.70

1.5

—

(3002256) Pathology report gross observation

1603

13687

1.20

9.63

1.3

—

(3037756) Immunofixation for Serum or Plasma

300

2037

1.48

9.57

1.7

1.8

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

323

2226

1.46

9.56

1.7

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

159

929

1.72

9.55

1.2

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

112

588

1.91

9.55

1.3

1.2

385.5

278.5

titre

0.24

(3028707) Methadone [Presence] in Urine by Screen method

187

1141

1.65

9.55

2.5

2.8

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

277

2.35

9.50

1.7

1.9

9.0

9.3

mg/l

0.15

218

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

141

799

1.77

9.43

1.1

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

168

1005

1.68

9.27

1.5

1.8

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

369

2631

1.41

9.11

1.9

1.7

40.7

41.4

nmol/l

0.22

357

2561

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

153

900

1.71

9.00

1.1

—

3.8

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

5.49

8.96

1.1

1.0

0.4

0.2

u/ml

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

347

2455

1.43

8.95

1.7

1.8

29.4

16.8

iu/l

0.19

124

896

(3016018) Differential panel - Cerebral spinal fluid

159

951

1.68

8.80

1.2

1.4

—

(21494755) Public health laboratory ask at order entry panel

821

10131

0.80

8.79

1.3

1.4

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

332

2.18

8.78

1.3

1.2

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

3.50

8.77

1.0

1.1

1.6

1.7

umol/24h

0.34

(4027681)

480

1.97

8.74

1.2

1.3

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

379

2.09

8.71

3.0

2.3

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

241

1597

1.52

8.69

1.1

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

295

2.24

8.68

1.1

1.3

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

237

1567

1.52

8.64

1.2

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

113

618

1.84

8.54

1.2

1.4

—

(3002619) Bacteria identified in Specimen by Culture

170

2.65

8.50

1.5

1.1

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

115

634

1.82

8.48

1.2

1.4

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

352

2.11

8.36

1.5

1.2

2.9

4.2

umol/l

3.30

329

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

250

2.33

8.32

1.2

1.1

95.3

88.6

0.59

120

(3033923) Metanephrine [Moles/time] in 24 hour Urine

178

2.59

8.30

1.1

0.6

1.0

umol/24h

0.50

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

161

2.68

8.28

1.2

0.8

65.7

mg/l

1.00

126

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

110

604

1.83

8.23

1.1

258.2

271.4

mg/l

0.31

516

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

103

554

1.87

8.23

1.1

8.1

8.7

iu/ml

0.10

131

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

113

626

1.81

8.22

1.2

1.1

42.3

43.0

mg/l

0.04

502

(1616796) Gas panel - Central venous blood

305

2143

1.43

8.21

4.0

3.6

—

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

5.34

8.19

1.1

1.0

0.2

0.1

u/ml

—

(3014271) Vancomycin [Susceptibility]

472

1.93

8.12

3.5

2.8

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

359

2602

1.39

8.10

1.3

1.2

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

130

754

1.73

8.09

1.7

1.3

1.5

1.4

promille

0.41

102

569

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

426

3176

1.35

8.07

1.9

1.7

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

260

2.28

8.05

1.2

1.1

95.9

88.5

0.75

123

(3035637) Corticotropin [Mass/volume] in Plasma

181

1147

1.59

8.01

1.4

1.5

—

(3037121) Protein [Mass/volume] in Urine

440

3306

1.34

7.92

3.3

0.4

0.3

g/l

0.46

205

1472

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

275

2.22

7.90

2.4

3.2

8.1

7.7

mg/l

0.20

227

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

105

576

1.83

7.90

1.1

—

(44790049)

166

1034

1.61

7.89

1.6

1.5

—

(44806118)

166

1034

1.61

7.89

1.6

1.5

—

(44790047)

166

1034

1.61

7.89

1.6

1.5

—

(44790048)

166

1034

1.61

7.89

1.6

1.5

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

498

1.89

7.88

1.1

5.7

9.3

nmol/l

0.35

112

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

301

2130

1.42

7.82

2.2

2.1

4331.5

4278.5

u/l

0.01

829

(3032057) Clostridioides difficile [Presence] in Stool

190

2.48

7.78

1.9

1.8

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

196

2.45

7.78

1.1

u/ml

0.04

102

(3008295) Osmolality of Serum or Plasma

152

932

1.64

7.71

1.3

1.4

277.5

278.6

mosm/kgh2o

0.17

103

734

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

244

1668

1.47

7.62

1.6

1.5

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

152

935

1.63

7.62

1.5

1.9

—

(3025577) Chromium [Mass/volume] in Blood

101

554

1.83

7.62

2.2

2.0

2.5

2.4

ug/l

0.05

465

(3023323) Follitropin [Units/volume] in Serum or Plasma

510

3940

1.31

7.58

1.3

29.6

33.5

iu/l

2.01

447

3371

(3021387) Prolactin [Units/volume] in Serum or Plasma

354

2600

1.37

7.41

1.6

1.7

295.0

305.1

mu/l

0.15

328

2361

(3026470) Cobalt [Mass/volume] in Blood

101

560

1.81

7.37

2.1

2.0

4.0

3.6

ug/l

0.22

502

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

213

1427

1.50

7.37

1.5

1.4

—

(3023410) Appearance of Cerebral spinal fluid

140

853

1.65

7.31

1.3

1.5

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

130

777

1.68

7.30

1.1

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

464

1.88

7.19

1.2

1.5

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

464

1.88

7.19

1.2

1.5

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

408

1.94

7.19

1.1

2.6

7.3

u/ml

1.65

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

789

9564

0.81

7.15

1.8

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

148

921

1.61

7.11

3.4

2.8

—

(1761868) Lipid panel - Serum or Plasma

3543

38326

0.90

7.04

3.0

2.8

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

125

748

1.68

7.01

1.1

1.2

—

(3009015) Lactate [Moles/volume] in Synovial fluid

3.49

6.97

1.2

6.8

6.7

mmol/l

—

(3004809) Band form neutrophils/100 leukocytes in Blood

231

1595

1.46

6.90

3.7

3.5

1.1

1.6

2.29

168

1259

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

138

851

1.63

6.90

1.3

1.6

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

260

1836

1.42

6.89

2.8

3.0

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

112

654

1.72

6.88

1.5

2.1

17.0

17.3

nmol/l

0.14

101

619

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

385

2900

1.34

6.87

1.5

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1761

15554

1.15

6.86

1.5

1.4

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

275

1968

1.41

6.76

1.7

0.9

0.8

nmol/l

0.36

228

1658

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

341

2.00

6.75

1.1

97.2

632.4

ng/l

1.39

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

105

608

1.73

6.66

2.0

1.7

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

491

1.82

6.65

1.2

—

(1002224) Polysomnography panel

529

4181

1.28

6.64

1.1

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

2041

18253

1.14

6.62

3.0

2.9

0.6

0.8

ug/l

13.38

1358

11752

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

429

1.87

6.54

1.1

u/l

0.03

198

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

959

8100

1.20

6.47

1.4

1.3

—

(4198724)

313

2.02

6.44

2.1

2.3

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

262

1880

1.40

6.37

1.5

1.4

—

(21494890) Protein electrophoresis panel - 24 hour Urine

151

971

1.56

6.37

2.0

2.2

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

123

753

1.64

6.36

1.3

1.2

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

295

2.04

6.32

1.2

0.3

g/l

0.12

227

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1437

12587

1.16

6.25

4.9

4.4

32.4

32.3

0.16

1004

8411

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

224

2.19

6.22

1.4

1.7

169.4

97.8

au/ml

—

(4024509)

140

890

1.58

6.22

1.6

1.5

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

518

1.76

6.16

2.6

2.8

863.4

1271.9

u/ml

0.77

513

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

260

1878

1.39

6.10

1.5

1.4

10.8

22.5

u/ml

1.89

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

205

1420

1.45

6.08

1.9

1.6

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

166

1104

1.51

6.03

1.2

55.8

62.2

u/l

0.69

116

735

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

106

637

1.67

5.92

1.2

72.7

91.7

u/l

2.06

546

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

236

2.12

5.88

1.1

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

237

1697

1.40

5.87

1.7

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

155

1024

1.52

5.83

1.1

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

239

1721

1.40

5.74

1.5

1.4

125.1

116.9

u/ml

0.26

374

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

182

1247

1.47

5.74

1.1

2.0

3.6

u/ml

2.80

611

(3000093) Morphology [Interpretation] in Blood Narrative

139

901

1.55

5.71

1.1

—

(3043410) Blood group antigens tested for on Red Blood Cells

259

2.05

5.71

1.8

1.5

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

187

2.25

5.71

1.3

1.4

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

239

2.10

5.71

1.1

1.3

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

103

621

1.66

5.70

1.2

19.4

23.1

u/l

0.51

525

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

318

2399

1.33

5.69

2.5

2.3

114.3

101.4

ug/min

0.20

193

1414

(3009214) Lutropin [Units/volume] in Serum or Plasma

301

2254

1.34

5.67

1.3

10.5

11.2

u/l

0.37

248

1829

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

214

2.15

5.63

1.1

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

401

1.83

5.60

1.4

1.7

2.3

10.5

nmol/l

0.76

335

(1001926) Buprenorphine [Presence] in Urine by Screen method

283

2105

1.35

5.58

2.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

296

1.96

5.56

1.0

1.1

—

(3029075) Extractable nuclear Ab panel - Serum

235

2.09

5.56

1.1

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

310

1.94

5.55

1.4

16.0

15.7

pmol/l

0.06

263

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

190

1322

1.44

5.55

1.6

1.5

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

222

2.12

5.54

1.1

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

269

2.01

5.54

1.3

2.4

1.5

0.9

ug/l

0.97

257

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

152

2.37

5.53

1.1

1.2

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

273

2024

1.36

5.50

5.5

5.8

780.3

1445.5

iu/ml

0.39

311

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

296

2223

1.34

5.48

1.6

1.5

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

191

2.20

5.45

1.3

1.2

—

(3003694) ABO and Rh group [Type] in Blood

3004

27766

1.11

5.44

1.4

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

2.90

5.44

2.4

2.1

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

117

2.57

5.44

1.3

1.5

140.2

116.0

ug/l

0.51

(3042631) Mycobacterium sp identified in Specimen

191

1339

1.43

5.37

2.7

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

180

2.23

5.33

1.3

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

489

1.72

5.32

1.5

2.1

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

489

1.72

5.32

1.5

2.1

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

489

1.72

5.32

1.5

2.1

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

489

1.72

5.32

1.5

2.1

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

260

2.00

5.29

2.2

2.5

108.3

148.7

au/ml

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

281

1.96

5.27

1.3

1.2

108.6

111.6

0.47

249

(3016038) Potassium [Moles/volume] in Urine

102

627

1.63

5.27

1.2

34.9

35.2

mmol/l

0.04

537

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

2.98

5.24

2.5

2.2

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

107

667

1.61

5.23

1.4

1.5

13.4

12.6

umol/l

0.54

101

628

(3019832) Treponema pallidum Ab [Presence] in Serum

732

6160

1.20

5.19

1.7

1.6

—

(3016879) Cocaine [Presence] in Urine

335

2586

1.30

5.14

2.0

2.1

—

(4133840)

259

1.97

4.99

1.2

—

(3045716) Anion gap in Serum or Plasma

409

1.76

4.99

2.1

2.4

8.4

9.5

mmol/l

2.02

307

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

179

2.18

4.98

1.4

1.2

102.5

80.1

1.09

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

352

1.82

4.94

2.9

2.2

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

100

623

1.61

4.93

1.9

2.6

464.1

525.6

e6/l

0.96

521

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

433

1.74

4.92

1.4

1.2

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

107

679

1.58

4.89

1.1

—

(3023183) Ammonium ion [Moles/volume] in Plasma

277

2100

1.33

4.86

2.2

2.7

32.3

33.8

umol/l

0.65

244

1772

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

2.70

4.83

1.2

1.3

0.2

0.3

nmol/l

0.33

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

235

2.00

4.82

1.1

—

(4015189)

249

1.97

4.80

2.5

2.0

—

(3016244) Insulin [Units/volume] in Serum or Plasma

467

1.70

4.78

3.3

3.5

30.4

26.6

mu/l

0.37

440

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

597

1.61

4.78

1.9

2.7

0.2

e9/l

0.31

522

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

243

1.98

4.76

1.6

0.3

0.4

ug/l

0.49

155

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

211

1541

1.38

4.74

2.7

1190.0

2293.3

u/ml

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

967

8408

1.16

4.67

3.4

3.7

1.2

mmol/l

0.09

867

7321

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

525

6340

0.82

4.66

1.5

1.4

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

166

1168

1.43

4.64

1.1

—

(3000764) Benzodiazepines [Presence] in Urine

354

2793

1.28

4.63

2.0

—

(3015183) Erythrocyte sedimentation rate

434

1.71

4.62

1.2

—

(3003721) Smooth muscle Ab [Units/volume] in Serum

3.34

4.59

1.1

—

3.1

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

178

1271

1.41

4.58

1.5

1.4

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

109

710

1.54

4.48

1.3

2.3

2.2

mmol/l

0.14

664

(40767503) Oxygen content in Capillary blood by calculation

270

2067

1.31

4.46

2.8

2.5

16.7

16.3

0.98

158

1060

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

184

1329

1.39

4.44

1.1

1.5

g/l

0.67

166

1195

(3028300) Cannabinoids [Presence] in Urine

355

2817

1.27

4.44

2.0

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

243

1.94

4.42

1.1

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

243

1836

1.33

4.41

1.3

1.2

—

(3020874) Milk IgE Ab [Units/volume] in Serum

509

1.63

4.40

1.0

0.4

1.9

u/ml

1.04

131

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

433

1.69

4.39

1.2

—

(3037556) Urate [Mass/volume] in Serum or Plasma

265

1.89

4.37

1.5

1.4

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

237

1.94

4.37

1.1

—

(3010375) cycloSPORINE [Mass/volume] in Blood

442

1.68

4.35

28.8

27.3

118.0

117.1

ug/l

0.04

364

(3027008) Opiates [Presence] in Urine

353

2808

1.26

4.34

2.0

1.9

—

(3016750) Collection duration of Urine

574

1.59

4.31

2.4

2.2

490.9

497.9

min

0.34

442

(3027923) C peptide [Moles/volume] in Serum or Plasma

489

1.64

4.31

1.5

1.4

1.1

1.2

nmol/l

0.69

372

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

489

1.64

4.31

1.1

—

(3010421) pH of Blood

326

2571

1.28

4.31

4.3

3.8

7.4

0.73

280

2168

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

520

1.62

4.30

1.2

1.0

1.1

ratio

1.44

189

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

391

1.72

4.29

1.6

2.3

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

337

2671

1.27

4.28

3.1

2.9

1.6

1.5

mg/l

1.46

306

2438

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

132

2.28

4.27

1.5

—

(3017704) Immunofixation for Urine

498

1.63

4.27

1.2

1.8

—

(3020876) Protein [Mass/time] in 24 hour Urine

120

810

1.49

4.20

1.9

2.1

1.1

1.3

g/24h

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

386

1.71

4.20

1.6

2.4

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

386

1.71

4.20

1.6

2.4

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

249

1907

1.31

4.13

3.4

3.0

0.8

nmol/l

0.93

202

1468

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

227

1717

1.33

4.12

1.3

1.2

290.0

276.1

u/ml

0.19

143

1090

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

457

1.64

4.11

2.4

2.0

110.6

153.5

ug/min

0.30

108

(3006442) Creatine [Moles/volume] in Serum or Plasma

100

653

1.54

4.10

1.9

1.5

70.0

74.0

umol/l

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

123

839

1.47

4.10

1.3

1.6

1.4

nmol/l

0.54

115

756

(3030313) Adrenal Ab [Titer] in Serum

3.08

4.07

1.1

1.0

—

(3042517) Benzodiazepines panel - Urine

2.71

4.07

1.2

2.5

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

3.19

4.05

1.1

1.2

—

(3034426) Prothrombin time (PT)

317

1.77

4.01

1.3

1.2

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

136

2.21

4.00

1.1

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

212

1595

1.33

4.00

1.2

1.3

22.5

39.5

u/l

3.20

192

1371

(3012501) Base excess in Blood by calculation

284

2225

1.28

3.99

4.3

3.9

2.7

2.6

mmol/l

0.17

202

1515

(3009466) Valproate [Moles/volume] in Serum or Plasma

192

1424

1.35

3.98

4.8

5.3

352.6

374.2

umol/l

1.38

169

1236

(3028433) Virus identified in Specimen by Culture

333

1.75

3.96

1.2

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

304

1.78

3.94

1.4

2.5

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

572

1.56

3.93

1.2

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

177

2.04

3.93

1.3

1.2

91.6

74.0

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

226

1.91

3.89

1.0

—

(3027944) Amphetamines [Presence] in Urine

344

2767

1.25

3.89

1.9

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

2.45

3.87

1.1

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

496

1.60

3.86

1.1

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

145

2.14

3.85

1.5

1.9

13.1

17.1

umol/l

1.29

145

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

631

1.53

3.85

1.1

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

634

1.52

3.77

1.1

—

(3011412) CD3 cells [#/volume] in Blood

132

930

1.42

3.74

1.8

2.4

1.2

1.1

e9/l

0.26

581

(37021550) Renin [Units/volume] in Plasma --upright

202

1.93

3.70

1.4

1.3

130.8

64.6

mu/l

0.69

151

(3009208) Meadow Fescue IgE Ab [Units/volume] in Serum

6.67

3.67

1.0

1.1

5.1

8.1

u/ml

—

(4146454)

145

1043

1.39

3.67

2.8

2.7

—

(3024869) Neuronal Ab [Presence] in Serum

162

2.04

3.64

1.1

—

(3004775) Volume in Urine collected for unspecified duration

116

805

1.45

3.59

2.6

2.2

663.6

662.4

0.01

552

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

459

1.59

3.58

1.2

1.3

75.1

56.7

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

2.35

3.56

1.1

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

651

1.49

3.56

1.6

1.5

5.9

5.3

u/l

0.15

309

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

118

2.21

3.50

8.3

9.3

5.1

5.6

mmol/l

0.68

118

(3014599) Egg white IgE Ab [Units/volume] in Serum

510

1.55

3.47

1.1

1.0

0.3

0.6

u/ml

1.12

115

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

356

1.66

3.42

2.5

3.1

24.9

28.3

umol/l

1.70

268

(3000034) Microalbumin [Mass/volume] in Urine

126

898

1.41

3.39

3.2

2.9

48.5

35.9

mg/l

0.26

638

(3009871) Measles virus Ab [Titer] in Serum

351

1.66

3.33

1.7

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1250

11314

1.12

3.32

3.2

4.3

24.6

26.8

ug/l

0.08

991

9194

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

225

1.82

3.31

1.3

1.2

401.4

306.8

pmol/l

0.49

172

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

108

2.22

3.31

1.3

1.1

—

(3006245) CD3-CD19+ cells/100 cells in Blood

329

1.67

3.30

1.8

2.1

9.3

10.4

0.25

305

(3026250) Tacrolimus [Mass/volume] in Blood

430

1.58

3.29

37.1

33.5

7.2

7.3

ug/l

0.18

384

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

8.57

3.26

1.2

1.1

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

129

2.10

3.22

1.2

1.1

—

(3001729) Color of Synovial fluid

2.58

3.20

1.8

1.7

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

112

791

1.42

3.20

1.2

166.0

195.3

titre

0.13

139

(3022493) Free Hemoglobin [Mass/volume] in Plasma

371

1.62

3.19

9.5

4.9

58.8

1161.6

mg/l

0.84

265

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

6.37

3.18

1.0

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

149

1105

1.35

3.18

1.2

1.1

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

2.63

3.12

1.2

1.1

—

(40768446) Kidney Pathology biopsy report

382

1.60

3.09

1.9

1.6

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

469

1.54

3.08

1.1

1.0

0.3

1.6

u/ml

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

2.58

3.03

1.0

1.1

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

4.29

2.99

1.0

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

319

2628

1.22

2.98

1.3

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

2.75

2.98

1.1

1.0

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

450

1.54

2.95

4.5

4.1

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

182

2338

0.78

2.95

1.4

1.5

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

141

1.99

2.94

1.2

1.3

—

(40762814) Titanium [Mass/volume] in Blood

148

1.96

2.93

2.5

2.3

3.4

4.1

ug/l

—

(3020491) Glucose [Moles/volume] in Blood

663

1.44

2.93

2.0

7.2

6.9

mmol/l

0.48

452

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

2.27

2.93

2.6

2.8

0.7

1.0

mmol/l

0.41

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

4.71

2.91

1.1

1.0

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

549

1.48

2.90

1.4

—

(3023199) Leukocytes [#/volume] in Pleural fluid

156

1183

1.32

2.90

1.5

9555.9

2555.2

e6/l

0.60

113

853

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

2.59

2.87

1.1

1.0

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

6.67

2.86

1.0

1.5

2.1

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

456

3904

1.17

2.81

3.0

3.7

1065.3

1217.3

u/ml

0.08

383

3364

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

2.64

2.79

1.0

1.1

9.0

13.1

u/l

0.36

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

695

1.41

2.78

1.6

1.8

—

(44806071)

110

2.09

2.77

1.1

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

104

2.12

2.73

1.0

1.1

0.7

0.2

u/ml

0.31

(3019174) dRVVT (LA screen)

2.43

2.70

1.1

1.2

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

142

1075

1.32

2.70

1.5

1.4

71512.4

48635.4

e6/l

0.24

630

(3017569) Oxygen content in Arterial blood

444

1.51

2.70

2.1

2.2

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

396

1.54

2.70

1.2

1.1

4.1

5.9

u/ml

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

219

1.74

2.67

1.3

101.7

129.0

nmol/l

0.93

163

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

234

1.71

2.67

1.2

1.1

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

693

1.40

2.66

1.5

2.1

—

(3036603) Volume of Urine

687

1.40

2.61

1.7

1.6

1929.4

2003.5

0.18

161

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

141

1.92

2.59

1.2

1.1

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

105

766

1.37

2.56

1.8

1.6

—

(3035285) Chloride [Moles/volume] in Venous blood

159

1236

1.29

2.52

2.7

2.2

105.9

105.3

mmol/l

1.31

159

1222

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

584

1.42

2.50

1.1

—

(3050794) Legionella sp Ab [Presence] in Serum

2.27

2.50

1.4

1.2

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

154

1195

1.29

2.48

1.0

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

312

0.45

2.46

1.5

—

(3041354) Potassium [Moles/volume] in Venous blood

158

1236

1.28

2.40

2.8

2.2

4.0

4.1

mmol/l

0.61

158

1222

(3051611) Lipemic interference index of Serum or Plasma

141

1087

1.30

2.40

3.9

3.3

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

182

1.76

2.38

1.1

1.0

—

(3013637) Mi-2 Ab [Presence] in Serum

182

1.76

2.38

1.1

1.0

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

182

1.76

2.38

1.1

1.0

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

182

1.76

2.38

1.1

1.0

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

823

0.67

2.38

1.2

1.5

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

483

1.45

2.36

1.4

1.6

—

(3035611) Eosinophils/100 leukocytes in Synovial fluid

2.50

2.35

2.0

1.8

0.6

0.4

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

354

1.53

2.33

1.9

1.8

89902.6

20045.5

u/ml

0.40

(3045683) HLA typing for celiac disease panel - Blood or Tissue

535

1.42

2.31

1.0

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

404

1.49

2.29

2.2

2.3

53.8

52.3

umol/l

0.15

337

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

388

1.50

2.29

1.1

100.0

97.2

0.27

304

(3032743) Legionella sp IgG Ab [Presence] in Serum

2.37

2.28

1.4

1.1

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

155

1220

1.27

2.27

2.8

2.2

—

(3042733) HLA Ab [Presence] in Serum

333

1.53

2.25

5.4

4.8

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

539

1.41

2.23

1.1

—

(3003434) Protein [Mass/volume] in Pleural fluid

169

1350

1.26

2.20

1.6

1.4

32.2

33.8

g/l

0.92

154

1216

(3047189) Immunofixation for 24 hour Urine

458

1.44

2.18

1.8

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

104

780

1.34

2.18

1.2

1.3

11.3

11.6

mmol/l

0.11

213

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

1110

0.73

2.17

1.5

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

151

1.79

2.15

1.1

1.0

5.7

7.2

mg/g

1.30

144

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

3.69

2.15

1.9

1.5

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

2.30

2.14

1.4

1.1

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

159

1266

1.26

2.14

1.1

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

167

1339

1.25

2.12

1.8

1.5

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

283

1.56

2.10

2.5

3.4

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

2.56

2.09

1.0

—

(3008037) Lactate [Moles/volume] in Venous blood

260

2186

1.19

2.08

3.7

2.9

1.5

1.6

mmol/l

2.23

255

2137

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

237

1.61

2.06

1.2

1.1

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

109

833

1.31

2.03

1.2

1.3

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

247

1.58

2.00

1.1

1.3

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

116

899

1.29

1.96

1.4

1.3

760.9

525.3

u/l

0.24

109

857

(3004451) EKG impression Narrative

452

1.42

1.96

1.4

1.2

—

(3005011) Chlamydia sp Ab [Titer] in Serum

119

1.85

1.96

1.6

1.7

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

156

1.73

1.95

1.3

1.2

102.4

651.9

ng/l

0.54

105

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

138

1097

1.26

1.92

1.6

1.9

400.0

1396.4

titre

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

258

1.55

1.91

1.1

—

(1175426) CD3 cells/100 lymphocytes in Blood

737

1.32

1.90

1.6

2.1

74.9

71.8

1.47

709

(3028717) Thiamine [Mass/volume] in Blood

1.92

1.89

1.1

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

1.96

1.89

1.1

1.3

—

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

515

1.38

1.88

2.2

2.4

198.7

203.1

u/l

0.30

508

(4281824)

106

1364

0.78

1.88

1.2

1.1

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

357

1.46

1.86

1.9

1.4

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

721

0.69

1.86

1.3

1.5

5.6

4.2

ug/l

0.25

575

(3018851) Theophylline [Moles/volume] in Serum or Plasma

2.08

1.86

1.6

43.8

41.4

umol/l

0.16

(3012441) Differential panel - Pleural fluid

129

1022

1.26

1.85

1.6

1.4

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

399

1.43

1.85

1.1

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

3.53

1.83

2.0

1.2

—

(21494434) Karyotype in Bone marrow

110

856

1.29

1.83

1.1

1.2

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

392

1.43

1.82

1.1

—

(40768800) Prostate Pathology biopsy report

171

2072

0.82

1.79

1.2

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

146

1.71

1.77

4.7

5.1

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

471

1.38

1.76

1.2

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

471

1.38

1.76

1.2

1.5

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

177

1.64

1.75

1.6

2.4

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

124

1.78

1.75

1.1

1.2

41.9

56.0

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

404

1.41

1.75

1.2

1.1

1860.5

1436.2

miu/ml

1.83

404

(3025315) Body weight

2.03

1.74

5.3

4.0

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

162

1.67

1.74

1.1

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

706

1.31

1.72

2.0

2.7

789.4

643.6

e6/l

0.84

269

(3000060) B lymphocytes [#/volume] in Blood

234

1.54

1.69

1.6

2.0

443.0

564.7

e6/l

0.11

119

(3025130) Human papilloma virus identified in Specimen

151

1233

1.23

1.69

1.6

1.7

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

735

1.29

1.68

1.1

287.8

287.1

mg/l

0.04

657

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

104

1.83

1.66

1.8

2.6

0.9

mg/l

0.11

(3019977) pH of Arterial blood

536

1.35

1.66

2.3

2.6

7.4

0.68

194

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

502

1.36

1.66

1.2

1.3

5.9

6.0

mmol/l

0.11

471

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

2.80

1.65

1.0

—

(3045788) Cell count panel - Pleural fluid

116

925

1.26

1.62

1.5

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

636

5797

1.10

1.61

2.6

3.7

75.5

58.0

u/ml

0.26

609

5588

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

714

1.29

1.60

1.3

15.9

13.9

u/l

0.16

662

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

723

1.29

1.60

1.6

2.1

13.8

14.5

0.22

302

(1761482) Bacteria [#/volume] in Urine by Culture

306

2673

1.15

1.59

5.0

3.9

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.82

1.56

1.1

1.2

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

144

1183

1.22

1.55

1.3

1.4

0.3

nmol/l

0.53

112

896

(3038515) Glucose [Moles/volume] in Venous blood

241

2074

1.17

1.55

3.9

3.0

7.3

7.7

mmol/l

2.05

236

2034

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

179

1503

1.19

1.54

1.1

66906.0

924.1

iu/ml

0.48

318

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

130

1.69

1.52

1.1

1.2

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

146

1.65

1.50

2.5

2.0

—

(3010503) CD19 cells [#/volume] in Blood

616

1.30

1.50

2.1

2.6

0.1

0.4

e9/l

1.36

598

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

405

3621

1.12

1.49

1.9

1.7

4.1

3.5

mg/l

0.40

316

2480

(3036782) Glucose [Moles/volume] in Pleural fluid

115

927

1.24

1.49

1.4

1.3

6.4

6.2

mmol/l

0.25

106

852

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

1.90

1.49

1.0

—

(40761536) Microorganisms panel - Urine sediment

907

8434

1.08

1.49

4.9

3.7

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

210

1.53

1.48

1.0

1.1

—

(3022689) Creatine [Moles/volume] in Urine

284

1.45

1.46

1.4

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

276

1.45

1.46

1.7

1.6

8.3

8.9

ug/l

0.57

276

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

2.50

1.45

1.0

1.2

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

519

0.69

1.41

1.1

1.2

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

397

1.36

1.39

2.8

2.7

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

380

1.37

1.39

1.8

2.1

2.0

umol/l

0.26

357

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

520

1.31

1.36

1.9

1.8

1.2

3.3

u/field

2.84

363

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

1.87

1.34

1.4

1.3

0.5

1.2

ml/s/173m2

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

1.87

1.34

1.5

1.2

48.8

47.2

mg/l

—

(3044009) aPTT.lupus sensitive (LA screen)

1.91

1.33

1.2

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

358

1.37

1.33

1.7

1.9

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

299

1.41

1.32

1.3

1.1

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

225

1.47

1.30

2.8

2.5

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

1053

0.80

1.29

1.5

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

152

1282

1.19

1.29

1.2

8.2

7.5

mmol/l

1.80

109

932

(40762887) Creatinine [Moles/volume] in Blood

2.78

1.28

1.2

1.3

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

226

1.46

1.28

1.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

124

1487

0.83

1.25

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

100

1223

0.82

1.24

1.4

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

528

0.72

1.24

1.1

1.4

—

(3052592) Norovirus Ag [Presence] in Stool

203

1.48

1.24

1.2

1.4

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

132

1105

1.20

1.23

1.9

1.6

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

100

1222

0.82

1.23

1.4

—

(3040151) Glucose [Moles/volume] in Capillary blood

135

1133

1.19

1.23

6.2

13.1

7.6

7.4

mmol/l

0.15

112

940

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

139

1.58

1.22

1.7

1.6

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

100

1220

0.82

1.22

1.4

—

(4035726)

934

9939

0.93

1.22

1.4

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

108

1.67

1.22

1.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

108

1.67

1.22

1.0

1.1

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

109

1318

0.83

1.21

1.4

1.5

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

100

1218

0.82

1.20

1.4

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

164

1.53

1.19

2.4

3.2

—

(3049242) von Willebrand panel - Platelet poor plasma

2.31

1.18

1.3

1.7

—

(3024471) HLA-A [Type]

341

1.35

1.17

1.0

—

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

1.93

1.16

1.2

1.3

66.8

40.9

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.72

1.14

2.9

2.3

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

118

1.61

1.14

2.2

2.7

0.3

0.6

u/field

1.05

118

(40768806) Pleura Pathology biopsy report

127

1070

1.19

1.13

1.5

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

378

1.32

1.13

1.1

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

1.78

1.10

1.0

1.1

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

1018

0.81

1.09

1.4

—

(40757373) Influenza virus identified in Isolate

201

1.44

1.09

2.1

1.6

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

2.38

1.09

1.2

1.3

—

(4212803)

104

1.64

1.09

1.0

1.1

—

(3006462) Nitrate [Presence] in Urine

451

1.29

1.08

4.6

2.9

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

1.76

1.06

1.1

—

(3005033) Fetal Nuchal fold Thickness US

1013

0.82

1.05

1.4

—

(3051593) INR in Capillary blood by Coagulation assay

454

1.28

1.04

7.6

11.0

—

(3008536) Aspergillus sp Ab [Presence] in Serum

187

1.44

1.03

1.6

2.4

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

643

1.23

1.02

1.3

1.1

—

(3024932) HLA-DR beta [Type]

333

1.32

1.01

1.1

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

2.00

1.00

1.0

1.1

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

1.84

0.98

1.0

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

165

1.46

0.96

1.2

2.0

41.3

44.5

pmol/l

0.08

138

(3020356) Listeria sp identified in Specimen by Organism specific culture

1.89

0.94

1.0

1.1

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

1.61

0.93

1.1

—

(4211845)

499

1.24

0.91

4.4

2.9

—

(21494815) CD4 cells/100 lymphocytes in Specimen

103

873

1.18

0.91

1.6

2.3

41.0

41.9

0.08

107

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

357

1.29

0.91

1.2

1.5

8.9

7.8

mmol/l

1.39

207

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

289

1.32

0.87

1.3

1.1

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

694

1.20

0.86

1.0

294.0

385.9

ng/l

0.88

493

(3000285) Sodium [Moles/volume] in Blood

128

1.49

0.85

1.2

1.1

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

695

1.20

0.85

1.0

755.7

722.4

ng/l

0.32

477

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

697

1.19

0.83

1.0

39.0

46.1

ng/l

0.62

483

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

488

1.23

0.83

3.0

3.5

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

1.69

0.82

5.1

5.3

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

275

1.31

0.81

1.4

1.2

265.2

335.5

ug/l

0.12

155

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

105

902

1.17

0.81

4.4

5.4

178.8

75.1

u/ml

0.31

270

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

284

1.30

0.81

1.2

—

(40758047) Lysozyme [Mass/volume] in Pleural fluid

1.55

0.81

1.9

1.1

11.1

10.3

mg/l

0.10

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

1.70

0.80

1.0

1.1

—

(3000012) Reticulocyte production index

563

1.21

0.80

1.4

1.5

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

0.00

0.79

0.0

1.0

—

(3051651) Icteric interference index of Serum or Plasma

628

1.20

0.79

5.0

3.7

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

803

1.17

0.79

2.3

2.1

2.7

1.9

u/field

0.55

309

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

148

0.61

0.78

8.7

6.0

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

149

0.60

0.78

4.3

3.0

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

1.56

0.78

1.1

1.2

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

575

1.20

0.77

1.7

3.1

40.2

36.5

0.78

193

(3042111) Morphology [Interpretation] in Bone marrow Narrative

191

1720

1.11

0.75

1.7

1.5

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.60

0.74

1.2

1.1

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

2.08

0.74

1.2

1.3

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.67

0.74

1.0

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

396

1.24

0.74

1.6

1.7

31.7

29.5

umol/l

0.79

378

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

108

1.48

0.73

1.1

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

992

0.86

0.73

1.6

1.7

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

139

1232

1.13

0.72

2.7

3.5

4.7

12.7

nmol/l

1.04

132

1199

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

1.62

0.71

1.1

—

(3010937) Rubella virus Ab [Presence] in Serum

1.75

0.71

1.1

—

(3048879) Bone marrow aspiration report

282

1.28

0.70

1.3

2.1

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

282

1.28

0.70

2.0

1.5

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

336

1.25

0.70

1.1

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

101

1.49

0.70

1.0

1.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

951

0.86

0.67

1.0

—

(3039443) Prostate specific Ag panel - Serum or Plasma

184

2028

0.91

0.67

1.5

1.6

—

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

1.63

0.66

1.0

0.0

0.3

u/ml

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

384

1.22

0.66

1.7

1.5

3075705.2

1388450.5

iu/ml

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

113

997

1.13

0.65

1.3

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

163

1.35

0.64

1.3

1.5

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

350

1.23

0.63

1.5

1.8

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

129

1.40

0.63

1.2

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

1.67

0.61

1.2

1.0

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

1.67

0.61

1.0

0.4

3.8

u/ml

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

1.48

0.60

1.0

1.1

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

1.57

0.60

1.1

1.0

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

123

1.38

0.57

1.6

1.5

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

283

1.24

0.56

2.3

2.5

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

283

1.24

0.56

2.3

2.5

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

540

1.17

0.56

1.2

1.1

27.7

27.9

u/l

0.01

415

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.54

0.55

1.2

1.1

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

449

1.18

0.54

1.1

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

1.48

0.53

1.0

1.1

8.1

8.4

mmol/l

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

543

1.16

0.53

1.1

107.4

89.7

u/l

0.38

431

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.49

0.53

4.7

5.4

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

360

0.81

0.52

2.1

1.8

26816.8

13615.3

e6/l

0.31

202

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

1.52

0.52

1.1

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

179

1.29

0.51

1.2

1.3

1.8

mmol/l

1.25

112

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

790

1.13

0.51

1.8

1.5

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

109

1.38

0.50

1.1

1.0

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

297

1.21

0.50

1.1

—

(3044242) Glucose [Moles/volume] in Arterial blood

463

1.17

0.50

1.9

2.0

—

(3045142) Bone marrow Pathology biopsy report

127

1153

1.10

0.49

1.3

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

101

1.39

0.49

1.1

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

411

0.83

0.49

2.1

1.9

843.7

3940.8

e6/l

0.78

287

(3034092) Cytoplasmic Ig cells/100 cells in Blood

128

1.33

0.47

19.1

7.3

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

688

0.87

0.47

1.1

1.3

1.7

1.4

g/l

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

102

1.37

0.47

3.3

2.0

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

147

1.29

0.45

1.1

1.0

106.9

79.7

ug/l

1.21

112

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

366

1.18

0.44

1.5

1.4

59.4

64.2

0.30

309

(3020393) Adenovirus Ag [Presence] in Stool

1.37

0.43

1.1

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

188

2017

0.93

0.43

2.5

3.5

24.1

39.8

u/ml

2.07

181

1943

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

239

1.21

0.42

1.1

1.3

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

237

2228

1.06

0.42

2.3

3.5

290.7

909.2

u/ml

1.13

215

2031

(3013293) Extractable nuclear Ab [Presence] in Serum

149

1.28

0.41

1.9

1.6

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

149

1.28

0.41

7.8

5.2

39.3

42.9

ug/min

0.13

117

(4038314)

1.52

0.41

1.0

1.3

—

(3021367) Citalopram [Moles/volume] in Serum or Plasma

0.00

0.41

0.0

1.4

—

116.7

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

213

1.22

0.40

1.2

1.4

39.6

22.9

1.35

182

(40765089) Chromosome analysis panel - Blood by G-banded

183

0.76

0.40

1.0

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

1.31

0.39

1.1

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

101

0.69

0.39

1.4

1.2

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

1.43

0.39

1.0

1.1

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

1.41

0.39

1.5

1.2

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

353

1.16

0.39

1.1

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

133

1.28

0.38

3.1

3.7

41.4

40.8

umol/l

0.04

115

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

551

1.13

0.38

1.8

1.5

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.35

0.37

1.3

2.9

—

(46235168) Fasting glucose [Moles/volume] in Blood

116

1.29

0.37

1.7

7.0

7.4

mmol/l

—

(3014891) Appearance of Pleural fluid

125

1.28

0.36

1.8

1.5

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.27

0.36

1.0

1.1

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

554

1.12

0.36

1.8

1.5

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

167

0.78

0.34

1.6

1.1

—

(3012565) Volume of 24 hour Urine

500

1.12

0.33

2.1

2.3

1961.2

1998.0

0.11

445

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

136

1.25

0.33

1.0

1.3

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

1.30

0.33

15.7

7.6

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

156

1.22

0.31

1.7

1.4

22.2

10.0

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

1.30

0.30

1.0

1.1

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

184

1.20

0.30

1.2

1.5

—

(3001556) Androgen free Index in Serum or Plasma

1.27

0.30

1.6

1.2

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

166

1.21

0.29

1.1

—

4.6

pmol/l

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

222

1.17

0.29

7.9

7.8

—

(3023383) Lactate [Moles/volume] in Pleural fluid

288

1.15

0.28

1.2

1.3

3.3

3.5

mmol/l

0.12

265

(3020650) Glucose [Presence] in Urine

270

0.85

0.28

1.5

1.4

—

(3017509) Phencyclidine [Presence] in Urine

1.32

0.28

2.7

1.4

—

(40768441) Liver Pathology biopsy report

791

0.92

0.26

1.4

1.3

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

178

1.18

0.26

8.0

7.4

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

225

1.16

0.26

1.0

1.1

—

(3001019) Free T4 and TSH panel - Serum or Plasma

496

5100

0.97

0.25

1.6

1.7

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

1.18

0.24

1.4

1.6

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

618

1.08

0.24

1.7

1.5

—

(3033799) Differential panel - Peritoneal fluid

350

0.89

0.24

1.7

1.8

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

1.26

0.24

5.7

6.1

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

133

1.20

0.24

1.7

1.9

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

1.28

0.24

1.9

2.0

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

255

1.14

0.24

1.1

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

313

1.12

0.23

1.5

1.3

0.8

2.5

4.18

268

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

0.77

0.22

6.4

8.7

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.74

0.22

1.0

1.1

—

(3036005) Urine sediment comments by Light microscopy Narrative

0.00

0.21

0.0

1.2

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.21

0.0

1.1

—

(3035880) pH of Pleural fluid

537

1.08

0.20

1.5

1.3

—

(3046861) Legionella sp Ag [Presence] in Urine

1.25

0.20

1.3

1.0

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

1.22

0.20

2.7

3.3

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

1.18

0.19

1.0

1.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

249

0.88

0.19

1.1

—

(44806420)

301

0.90

0.18

2.4

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

1.17

0.17

1.0

1.5

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

174

0.86

0.17

1.6

1.7

—

(3051101) Glucose [Moles/volume] in Cord blood

193

0.88

0.15

4.5

6.4

—

(44786800) Granulocytes/100 leukocytes in Body fluid

140

1.14

0.15

1.5

1.3

21.5

23.1

0.08

112

(3016228) CD19 cells/100 cells in Blood

420

1.07

0.14

1.8

2.1

7.0

8.9

0.61

409

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

774

1.05

0.13

1.8

1.3

125.0

68.5

pmol/l

0.46

240

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

108

0.83

0.13

1.1

1.2

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

217

2223

0.98

0.12

3.9

3.2

22.7

28.3

mg/l

1.82

144

1424

(3002523) Influenza virus A Ag [Presence] in Specimen

139

1433

0.97

0.12

1.0

1.1

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

251

0.92

0.12

1.5

1.3

31.1

30.4

g/l

0.03

194

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

134

1300

1.03

0.11

1.9

2.1

32.5

32.8

0.35

134

1289

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

153

1.11

0.11

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

153

1.11

0.11

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

669

0.96

0.11

6.4

6.7

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

1004

0.97

0.11

2.4

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

125

1.12

0.10

1.8

1.2

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

125

1.12

0.10

1.1

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

1.14

0.10

1.0

—

(40758292) HTLV I+II Ab panel - Serum

164

1.10

0.09

1.3

1.4

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

1.09

0.09

1.2

1.8

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

203

1.08

0.09

1.3

1.1

—

(3011325) HIV 1+2 Ab [Presence] in Serum

1.06

0.09

1.0

—

(40768795) Lymph node Pathology biopsy report

110

1132

0.97

0.09

1.2

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

1.04

0.09

1.2

1.8

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

594

0.96

0.09

1.1

—

(3036525) Urea [Moles/time] in 24 hour Urine

1.11

0.09

2.5

3.1

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

1.11

0.09

1.2

1.1

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

1.07

0.08

1.0

1.2

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

0.83

0.08

1.6

1.4

370.0

319.3

umol/24h

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

195

0.92

0.08

1.9

2.3

7.3

7.9

mmol/l

—

110

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

127

1.10

0.07

1.0

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.84

0.07

1.0

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

286

0.94

0.07

1.4

1.5

16.1

13.0

g/l

0.70

215

(3029396) Erythrocyte agglutination [Presence] in Blood

147

1.09

0.07

1.9

2.7

—

(40768793) Breast Pathology biopsy report

248

2515

0.99

0.07

1.3

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

216

1.06

0.06

1.8

2.9

74.5

136.9

ng/l

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

354

1.05

0.06

1.6

1.9

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

821

0.97

0.06

1.4

1.5

1.0

g/l

0.02

815

(3032868) Hemoglobin electrophoresis panel in Blood

1.11

0.05

1.5

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

257

1.05

0.05

8.1

8.2

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

139

1.08

0.05

1.2

1.3

4.2

0.9

mmol/l

—

(3035933) Granulocytes/100 leukocytes in Blood

232

0.95

0.05

1.5

1.9

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

345

3425

1.01

0.04

1.4

1.3

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

252

2500

1.01

0.03

1.5

1.4

93.9

153.5

pmol/l

3.63

245

2439

(40765096) Chromosome analysis panel by Banding

300

0.97

0.03

1.1

1.2

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

189

0.95

0.03

1.1

1.2

—

(3003740) Influenza virus B Ag [Presence] in Specimen

142

1435

0.99

0.03

1.0

1.1

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

218

0.96

0.02

1.3

1.7

2.7

2.2

ug/l

0.13

129

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

153

1.05

0.01

1.1

—

(3044007) Cell count panel - Peritoneal fluid

326

0.98

0.00

2.3

1.7

—

(21494814) CD8 cells/100 lymphocytes in Specimen

409

1.00

0.00

1.9

2.1

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

309

1.00

0.00

1.4

1.9

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

971

1.00

0.00

1.2

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

831

1.00

0.00

1.2

—

(40760866) Procollagen type III.N-terminal propeptide [Units/volume] in Serum

0.00

0.0

1.0

—

(40763629) HC gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.00

0.0

1.3

—

(3045462) Protein/Creatinine [Ratio] in Urine

0.99

0.00

2.4

3.7

55.5

38.5

g/mol

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.95

0.00

1.0

—

(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3002853) Influenza virus B Ab [Titer] in Serum

0.00

0.0

1.0

—

(3029612) Listeria sp Ab [Titer] in Serum

0.00

0.0

1.1

—

(3018834) Bilirubin.total [Presence] in Urine by Test strip

0.89

0.00

2.8

3.4

—

0.0

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

35.2

—

(3041806) Other cells [#/volume] in Blood by Manual count

180

1.00

0.00

1.8

1.5

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

0.00

0.0

1.0

—

(3022670) pH of Venous cord blood

0.00

0.0

1.2

—

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.0

1.0

—

(3022475) Manganese [Moles/volume] in Blood

0.87

0.00

1.7

1.3

—

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

0.94

0.00

1.0

1.4

6.4

15.2

pmol/l

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

0.96

0.00

2.9

2.4

—

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3025566) Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

0.0

1.0

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

0.0

1.0

—

(40758358) Immune stain study

0.89

0.00

1.0

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

0.00

0.0

1.0

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

190

1.00

0.00

2.5

6.1

52.4

72.0

u/l

—

Mortality – FinRegistry

↥

Association

Association between endpoint M13_SOFTOVERUSE and mortality.

Females

Parameter	HR [95% CI]	p-value
M13_SOFTOVERUSE	1.099 [1.0, 1.21]	0.049
Birth year	0.995 [0.99, 1.0]	0.188

During the follow-up period (1.1.1998 — 31.12.2019), 4657 out of 32082 females with M13_SOFTOVERUSE died.

Males

Parameter	HR [95% CI]	p-value
M13_SOFTOVERUSE	1.354 [1.23, 1.49]	< 0.001
Birth year	0.989 [0.98, 1.0]	0.012

During the follow-up period (1.1.1998 — 31.12.2019), 4823 out of 29525 males with M13_SOFTOVERUSE died.

Mortality risk

Mortality risk for people of age

years, who have M13_SOFTOVERUSE.

N-year risk	Females	Males
1	0.123%	0.297%
5	0.684%	1.546%
10	1.722%	4.1%
15	3.293%	7.919%
20	5.791%	13.128%

Relationships between endpoints

↥

Index endpoint: M13_SOFTOVERUSE – Soft tissue disorders related to use, overuse and pressure

GWS hits: 1

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Soft tissue disorders related to use, overuse and pressure

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints